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Summary 
 
Integrins are cell adhesion receptors which mediate interactions between the extracellular matrix and the 
actin cytoskeleton. They are heterodimers composed of α and β subunits. As adhesion receptors, integrins 
are important for cell-cell and cell-matrix interactions and therefore are essential for the structural 
integrity of an organ. Moreover, integrin-extracellular matrix interactions play important roles in the 
coordinated integration of external and internal cues that are essential for proper development. β1 integrin 
is the most widely expressed integrin and controls various developmental processes, including 
neurogenesis, chondrogenesis, skin and hair follicle morphogenesis, and myoblast fusion.  
To determine the role of β1 integrin in normal development of the mouse mammary gland, with a 
particular emphasis on how β1 integrins influcence proliferation, differentiation and apoptosis; we 
examined the consequence of conditional deletion of β1 integrin in mammary epithelia. Itgβ1flox/flox mice 
were crossed with WAPiCre transgenic mice, which led to specific ablation of β1 integrin in luminal 
alveolar epithelial cells. In the β1 integrin mutant mammary gland, individual alveoli were disorganized 
resulting from alterations in cell-basement membrane associations. Activity of focal adhesion kinase was 
also decreased in mutant mammary glands. Luminal cell proliferation was strongly inhibited in β1 integrin 
mutant glands, which correlated with a specific increase of p21Cip1 expression. In a p21Cip1 null 
background, there was a partial rescue of the proliferation defect, as measured by incorporation of 
Bromodeoxyuridene into S-phase cells. These data provide in vivo evidence linking p21Cip1 to the 
proliferative defect observed in β1 integrin mutant glands. A connection between p21Cip1 and β1 integrin 
as well as focal adhesion kinase was also established in primary mammary cells and an established cell 
line. Finally, transplanted mammary tissue from β1 integrin mutant females failed to repopulate recipient 
mammary glands, suggesting for the first time that β1 integrin may be required for the maintenance of 
mammary progenitor cells. 
Overall, we found β1 integrin has multiple roles in mouse mammary gland development. Ablation of β1 
integrin in luminal alveolar cells affects proliferation at early lactation, and the integrity of alveolar lumen 
structures during lactation. The results also suggest that β1 integrins are necessary for mammary 
progenitor cell proliferation and/or survival during mammary gland remodeling.  
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• Aims of the Ph.D. Project   
 
• To determine the role of β1 integrin in the normal development of mouse mammary gland. 
• To investigate the molecular mechanisms for the phenotypes we observed in vivo.  
• Establish an in vitro system that mimics the effects of deletion of the integrin β1 in the mouse. 
 
 
Results 
  
• Conditional deletion of β1 integrin in the mammary gland. 
• Function of mammary gland was impaired in β1 integrin mutant mice. 
• β1 integrin-mutant mammary glands have defects in alveolar integrity. 
• β1 integrin mutant mammary glands show an increase in apoptosis at involution, but not during lactation. 
• Loss of β1 integrin correlates with reduced mammary cell proliferation and upregulation of p21cip1  
• Ablation of β1 integrin impairs focal adhesion signalling. 
• Loss of either β1 integrin or FAK induces p21Cip1 upregulation in primary mammary cells. 
• Absence of p21cip1 rescues impaired BrdU incorporation in mammary cells of β1 integrin mutant mice. 
• Using an in vitro model to further mimic the proliferation defect after loss of β1 integrin. 
• Loss of β1 integrin leads to a defect in alveolar cell proliferation during a second pregnancy. 
 
Conclusion 
 
Discussion 
• Functional differentiation was normal in integrin β1 mutant glands 
• β1 integrin deletion results in loss of epithelial integrity 
• Loss of β1 integrin is not sufficient to trigger apoptosis in alveolar cells.   
• β1 integrins have a key role in the proliferation of mammary epithelial cells in vivo and in culture 
• A possible role for β1 integrins in the mammary stem cells 
• β1 integrins in breast cancer 
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Materials and Methods 
• Antibodies 
• Mouse strains and generation of mammary specific β1 mutant mice. 
• Pup Weight Analysis 
• Milk Annalysis 
• Mammary gland whole mounts 
• Histology and immunofluorescence 
• Electron microscopy 
• Isolation and assays with primary mammary cells 
• Transplantation of mammary epithelium into cleared fat pads of recipient mice 
• Lysate preparation, immunoprecipitation and western blot analysis. 
• MDA-MB-231 cell culture, siRNA transfections and luciferase assays 
• Flow cytometric analysis 
• Extraction of RNA and RT-PCR analysis of p21Cip1 
 
Reference 
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Introduction 
 
Part I Integrins: The basic machinery for cell adhesion 
 
In order to function as a tissue, epithelial cells must have the right shape and structure to pack together 
with their neighbors. Therefore, tissue formation in normal physiology requires cell adhesion. Cell 
adhesion governs, e.g., embryonic morphogenesis, angiogenesis, organogenesis, inflammation and tissue 
repair. Two types of adhesion, cell-cell adhesion and cell-matrix adhesion, are relevant for these processes. 
In this chapter, I will introduce the various cell adhesion junctions and adhesion receptors with an 
emphasis on integrins, the major extracellular matrix receptors. 
 
1.1 Cell adhesion receptors 
 
Cell-cell interactions, as well as cell-ECM interactions, are indispensable for normal tissue architecture. In 
mammals, adhesion between epithelial cells is generally mediated by three types of junctions: tight 
junctions (TJs), adherens junctions (AJs), and desmosomes, which together constitute the intercellular 
junctional complex (Perez-moreno et al. 2003). The complexes contain transmembrane receptors, usually 
glycoproteins that mediate binding at the extracellular surface and determine the specificity of the 
intracellular response. 
 
  
Fig.1. Composition of Three Types of Intercellular Junctions (A). 
Diagram of the three major types of intercellular junctions in 
epithelial cells. (B) Electron micrograph depicting the ultrastructure 
of adherens junctions, desmosomes, and tight junctions between two 
murine intestinal epithelial cells. (Perez-Moreno M. et al. 2003) 
 
Each of the junctions possesses unique morphological characteristics, composition, and functions. Tight 
junctions are one mode of cell-cell adhesion in epithelial and endothelial cellular sheets. They act as a 
primary barrier to the diffusion of solutes through the intercellular space, create a boundary between the 
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apical and the basolateral plasma membrane domains, and recruit various cytoskeletal as well as signalling 
molecules at their cytoplasmic surface. The adherens junction is a cellular structure found near the apical 
surface of polarized epithelial cells. Recent evidence has uncovered a key role for AJs not only in 
directing coordinated cellular organization and movements within epithelia, but also in transmitting 
information from the environment to the interior of cells (Perez-Moreno M. et al, 2003). Desmosomes are 
prominent cellular structures especially abundant in tissues that experience mechanical stress, e.g. in skin. 
Cell adhesion involves specific biomolecules such as memebrane anchors and receptors, extracellular 
ligands and cytoskeketal components. An important step in the formation of cell adhesion complexes is 
the clusting of the adhesion receptors involved, such as integrins or cadherins. Cadherins constitute a large 
family of glycoproteins comprised of an extracellular domain responsible for cell-cell interactions, a 
transmembrane domain, and a cytoplasmic domain that frequently is linked to the cytoskeleton. Cadherins 
are found in both adherens junction and demosomes and play a key role in calcium-dependent cell-cell 
interactions. AJs are cadherin-dependent adhesive structures that are intricately linked to the actin 
microfilament network. E-cadherin is typically the cadherin found in the adherens junction. While 
desmosomes are formed by interactions between desmosomal cadherins linked to intermediate filaments.  
At the adherens junctions the intracellular domain of cadherins specifically interacts with catenins; 
catenins serve to link the cadherin to the actin cytoskeleton and also function in cellular signaling 
(Wheelock and Johnson, 2003). Catenin is present in two compartments: a membrane-associated form 
couples E-cadherin to the cytoskeleton, and a cytoplasmic form is associated with a Wnt signaling 
complex that includes the serine/threonine kinase GSK3β, axin, APC, and β-catenin.  
 
Cadherins have been implicated in a number of signaling pathways that regulate cellular behavior. It was 
found that cadherin function is critical in normal development, and alterations in its function have been 
implicated in tumorigenesis (Hajra & Fearon 2002). Changes in the normal expression pattern of the E-
cadherin/catenin complex have been found in various human cancers. In breast cancer, generally speaking, 
partial or total loss of E-cadherin expression correlates with loss of differentiation characteristics, 
acquistion of invasiveness, increased tumor grade, metastatic behavior and poor prognoses. While forced 
expression of E-cadherin decreased proliferation of different mammary carcinoma cell lines, suggesting 
that E-cadherin is a potent tumor suppressor of breast cancer (Berx  &Van Roy, 2001). 
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Both in cell-cell adhesions and cell-ECM adhesions, the associated cytoplasmic proteins of the adhesion 
receptors structurally link them to the cytoskeleton, thereby establishing molecular lines of 
communication to other cell-cell junctions and to cell-substratum junctions. The linkage of cell-cell 
junctions to the cytoskeleton allows single cells of an epithelial sheet to function as a coordinated tissue. 
Additional companion proteins connect structural and signaling elements, and thus intercellular junctions 
function to integrate a number of cellular processes ranging from cytoskeletal dynamics to proliferation, 
transcription, and differentiation.  
 
1.2 Integrins and cell adhesion 
 
As we already mentioned, tissue formation in animals requires both cell-cell contacts and cell-matrix 
contacts. At the cytoplasmic face, both of the contacts are anchored by direct contact between the 
transmembrane proteins and microfilaments. Cell-cell contacts are specified by transmembrane proteins of 
the cadherin family, while cell-matrix contacts contain proteins of the integrin family. It is becoming 
increasingly clear that integration of information received from cell-cell signaling, cell-matrix signaling, 
and growth factor signaling determines ultimate cellular phenotype and behavior. 
 
  
  
 
 
 
1.2.1. Cell-matrix contacts  
Cell–matrix contacts are specialized 
receptors bind to their extracellular m
cytoskeleton. Cell–matrix contacts t
fundamental features of the cells and
have been characterised by their mor
criteria. Cell-matrix contacts can exi
 Fig.2. Simple epithelia comprised of one layer of cells attaches to the basement 
membranes by focal contacts (orange squares) and to adjacent cells via adherens 
junctions (black rectangles) and desmosomes (pink ovals). Tight junctions (blue 
circles) contribute to the maintenance of apical-basolateral polarity. The plane of 
the mitotic spindles aligns perpendicular to the basement membrane allowing 
lateral expansion of the cells.  (Perez-Moreno.M.et al., 2003) 
 
 
zones at the cell surface, where activated or clustered adhesion 
atrix (ECM) ligands and link intracellularly to components of the 
hus bridge the extracellular and intracellular milieux and are 
 tissues of multicellular organisms. Different cell–matrix contacts 
phology or by biochemical composition, or a combination of both 
st as focal complexes, focal adhesions, fibrillar adhesions, three 
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dimensional matrix adhesions and hemidesmosomes. Some matrix contacts, such as hemidesmosomes, are 
specific to particular differentiated cell types, while others occur in many cell types.  
The best characterized and largest of these structures is the focal adhesion (FA; also known as a focal 
contact). These adhesions are transient in nature, and form in many types of cells that are cultured on a 
substrate coated with ECM. All adherent cells bind to the ECM through integrins—transmembrane 
receptors that bind to specific motifs on numerous ECM proteins (Ruoslahti E. 1996). The binding of 
integrins to the ECM causes them to cluster and leads to the recruitment of a battery of cytoplasmic 
signaling and structural proteins to form FAs at the site of integrin clustering. Numerous structural 
proteins (e.g., vinculin, talin, α-actinin, and paxillin) act as scaffolding proteins that strengthen cell 
adhesion by anchoring FAs to the actin cytoskeleton (Miyamoto et al. 1995). Other types of cell-matrix 
adhesions that have been further identified—focal complexes, fibrillar adhesions and three dimensional 
matrix adhesions—are structurally similar to FAs but differ subtly in composition and morphology 
(Cukierman et al. 2001; Zamir E et al. 2000). Hemidesmosome are extremely large structures that form 
strong bonds between epitheial cells and the underlying interstitial ECM through a chain of molecular 
interactions. Instead of linking to the actin-based cytoskeleton, hemidesmosomes contain adaptor proteins 
which bind to intermediate filaments. The cell-matrix contacts are actually dynamic assemblies with 
above twenty proteins in a complex and all these contacts have essential roles in normal physiology and 
there are many contexts in which abnormalities of cell–matrix contacts lead to chronic and life-threatening 
diseases. 
 
1.2.2.Integrins are the major ECM receptors  
 
As we previously discussed, cells adhere to the ECM and to each other through specific classes of 
transmembrane adhesion receptors. These receptors bind to ligand extracellularly and provide an anchor to 
the intracellular cytoskeleton via cytoplasmic scaffolding proteins. Linkages between external cellular 
contacts, adhesion receptors, and cytoskeleton provide a means for bidirectional communication between 
the inside and outside of a cell. The major transmembrane ECM receptors in these cell-ECM adhesion 
sites belong to the integrin family. In addition to integrins, several other membrane molecules were 
recently reported to localize to focal contacts, including proteoglycans (Zimmermann and David, 1999), 
glycosaminoglycan receptors (Borowsky and Hynes, 1998), as well as signaling molecules (Yebra M et al. 
1999), however, the role of these components in mediating or regulating adhesion is unclear.  
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Integrins comprise a large family of cell surface receptors that are found in many species, ranging from 
sponges to mammals. They are composed of two subunits, α and β. There are several α- and β- subunit 
isoforms; to date 8 α and 8 β subunits have been identified. The receptors always contain one α chain and 
one β chain and each α β combination has its own binding specificity and signaling properties. A specific 
ECM molecule can nevertheless be bound by different types of integrins, and specific integrins can bind to 
different types of ECM molecules. For example, functionally, β1 integrins are a set of cellular receptors 
for extracellular matrix proteins that include fibronectin, collagen, and laminin. 
Integrin α and β subunits contain a large extracellular domain responsible for ligand binding, a single 
transmembrane domain and a cytoplasmic domain. The short cytoplasmic domain of integrins binds a 
variety of intracellular proteins including actin binding proteins like vinculin or talin, and also some 
signaling kinases like focal adhesion kinase (FAK). The extracellular domains of integrins also contain 
multiple binding sites such as the RGD binding site (about 50% of the integrins). As integrins bind to their 
ligand, they change from an inactive to an active configuration and become clustered in the plane of the 
cell membrane and associate with a cytoskeleton and signaling complex that promotes the assembly of 
actin filaments. The reorganization of actin filaments into large stress fibers, in turn, causes more integrin 
clustering, thus enhancing the matrix binding and organization by integrins in a positive feedback system. 
As a result, ECM proteins, integrins, and cytoskeletal proteins assemble into aggregates on each side of 
the membrane. Well-developed aggregates can be detected by immunofluorescence microscopy and are 
known as focal adhesions and ECM contacts (Burridge & Chrzanowska-Wodnicka, 1996). In this manner, 
integrins serve as integrators of the ECM and cytoskeleton, the property for which integrins are named. 
 
Fig.3. Integrins can adopt inactive and active 
configurations, which differ by change in relative 
orientation of the α− and β− subunits. The active 
orientation has enhanced affinity for both external 
and cytoplasmic ligands. Binding of ligand on 
either side promotes the change to active form, so 
cytoplasmic ligands can promote binding to ECM, 
and ECM binding can enhance interaction with 
cytoplasmic ligands or binding partners. 
(Schwartz, M.A. 2001). 
 
 
  
  
 
 
 
 
 
1.3 Downstream pathways of integrins 
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 Integrin-ligand interactions are accompanied by clustering and activation of the integrins on the cell 
surface, which is also accompanied by the transduction of signals into intracellular signal transduction 
pathways that mediate a number of intracellular events. Integrins transduce a great many signals. The 
majority of signalling molecules implicated in ECM–integrin interactions appear to be rather ubiquitous 
mediators of signal transduction. For example, Miyamoto et al. (Miyamoto er al. 1998) showed that at 
least 20 different proteins, including Rho GTPases, Raf, Ras, FAK, and MAPKs such as extracellular-
signal-regulated kinases (ERKs), can be recruited to the ECM ligand/integrin-binding site. In an attempt to 
understand how these intracellular mediators may contribute to specialized patterns of gene expression 
and cell behaviour, we will focus primarily on FAK, shc and ERK/MAPK pathways. 
 
1.3.1 The FAK/Src Pathway 
Integrins activate various protein tyrosine kinases, including focal adhesion kinase (FAK), Src family 
kinases, and Abl, and a serine-threonine kinase, integrin-linked kinase (ILK) (Giancotti & Ruoslahti, 
1999). The integrin-dependent pathways involving FAK and Src-family kinases have been studied in 
some detail. 
Focal adhesion kinase (FAK) is a tyrosine kinase which is commonly found in integrin mediated focal 
adhesions. It is a critical component of the focal adhesion and provides both structural and kinase activity 
to the focal contact. The FAK pathway is activated by most integrins. The activation of FAK is not well 
understood, but it is coupled to the assembly of focal adhesions. FAK may be recruited to nascent focal 
adhesions because it interacts, either directly or through the cytoskeletal proteins talin and paxillin, with 
the cytoplasmic tail of integrin β subunits. Upon activation, FAK autophosphorylates Tyr397, creating a 
binding site for the Src homology 2 (SH2) domain of Src or Fyn. The Src kinase then phosphorylates a 
number of focal adhesion components. The major targets include paxillin and tensin, two cytoskeletal 
proteins that may also have signaling functions, and p130CAS, a docking protein that recruits the adapter 
proteins Crk and Nck. FAK also combines with, and may activate, phosphoinositide 3-OH kinase (PI 3-
kinase), either directly or through the Src kinase. Finally, there is evidence that Src phosphorylates FAK at 
Tyr925, creating a binding site for the complex of the adapter Grb2 and the Ras GAP exchange factor 
mSOS. These interactions link FAK to signaling pathways that modify the cytoskeleton and activate 
mitogen-activated protein kinase (MAPK) cascades (Giancotti & Ruoslahti, 1999).  
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A number of observations strongly suggest that activation of FAK by integrins plays a central role in 
initiating many of the signals that regulate growth. For example, mutation of tyrosine residues critical for 
FAK autophosphorylation prevents integrin-mediated proliferation. Also, oncogenic transformation of 
cells, which abolishes the requirement for anchorage-dependent growth, activates FAK. Consistent with 
this, introduction of constitutively active FAK leads to cell transformation, anchorage-independent growth 
and the suppression of apoptosis (Boudreau NJ & Jones PL, 1999). 
 
1.3.2 The Fyn/Shc Pathway 
It is becoming clear that, like binding to the ECM, integrin signalling is determined by both α and β 
subunits. Several integrins interact, through the extracellular or transmembrane domain of their α−subunit, 
with other membrane proteins. For example, in addition to activating FAK, some β1 and αv integrins also 
activate the tyrosine kinase Fyn and, through it, the adapter protein Shc. In this pathway, caveolin-1 
appears to function as a membrane adapter, which couples the integrin α  subunit to Fyn. Upon integrin 
binding to ECM, Fyn becomes activated, and its SH3 domain interacts with a proline-rich site in Shc. Shc 
is then phosphorylated by Fyn at Tyr317 and combines with the Grb2-mSOS complex. Although most 
integrins interact with caveolin-1 and Fyn, only a subset of integrins can activate Fyn and thereby recruit 
Shc: Perhaps these integrins are associated with an activator of Fyn, such as a phosphatase that removes 
the phosphate group from the autoinhibitory tyrosine residue in Fyn. Yes and Lck are known to be 
enriched in rafts and may mediate the activation of Shc when Fyn is not expressed. 
The cytoplasmic domain of the β-subunit also contributes to the specificity of integrin signalling. For 
example, the unique, long cytoplasmic tail of integrin β4 allows α6β4 to recruit Shc by a mechanism 
distinct from that used by β1 and αv integrins: upon α6β4 binding to the ECM, the β4 tail is 
phosphorylated on tyrosine residues by an integrin-associated kinase and binds to Shc directly (Giancotti 
& Ruoslahti, 1999). 
 
 
 
 
 
 
 
 
 13Fig.4.Model of the (A) FAK and (B) Shc pathways. (Giancotti & Ruoslahti, 1999) 
 1.3.3 The Erk-MAPK Pathway 
The Activation of mitogen activated protein kinase (MAPK) occurs after integrin-ligand binding (RGD 
peptides, fibronectin, laminin), resulting in the translocation of Erk from the cytoplasm to the nucleus. We 
already mentioned that both FAK and Shc can contribute to the activation of the Ras–extracellular signal-
regulated kinase (ERK) MAPK cascade. MAPK can also be activated by integrin linked kinase (ILK) in a 
FAK independent pathway. The relative contribution of each pathway may depend on the cell type and 
perhaps also on how far the adhesion process has progressed. In many cell types, Shc appears to be 
responsible for the initial high-level activation of ERK upon cell adhesion. FAK, which is activated more 
slowly, may sustain the ERK activation. The integrins that do not activate Shc are weak activators of ERK 
and cell proliferation. The ability of integrins to activate ERK may be especially important when the 
concentration of growth factors available to the cell is limited. In this setting, proliferation is likely to 
require costimulation of ERK through integrins and growth factor receptors (Giancotti & Ruoslahti, 1999). 
 
1.3.4 Partnership with growth factors 
Integrins are not only signal on their own but are also necessary for optimal activation of growth factor 
receptors. The receptors for insulin, platelet derived growth factor (PDGF), epidermal growth factor 
(EGF), and vascular endothelial growth factor (VEGF) are optimally activated by their ligands only under 
appropriate cell attachment conditions (Giancotti & Ruoslahti, 1999). Treatment of endothelial cells with 
beads coated with an Arg-Gly-Asp (RGD) tripeptide or with fibronectin leads to coaggregation not only of 
β1 integrins and FAK, but also of high affinity receptors for basic fibroblast growth factor (bFGF) in the 
newly assembled focal adhesions (Miyamoto S et al.1996). The aggregation of the growth factor receptors 
results in their partial activation, possibly bringing growth factor signaling closer to a threshold of 
manifest activity and enabling cross talk between integrins and growth factor receptors. Although a 
systematic analysis has not been conducted, certain integrins appear to be preferentially associated with 
specific growth factor receptors. Thus, the αvβ3 integrin can be immunoprecipitated in complexes with 
the insulin, PDGF, and VEGF receptors (Soldi R., et al 1999), whereas α5β1 and perhaps other β1 
integrins associate with the EGF receptor (Miyamoto S et al.1996) 
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 1.4 Control of cell shape, growth and survival by integrins  
 
The formation of cell adhesion complexes by integrins assures substrate adhesion as well as targeted 
location of actin filaments and signalling components, and hence is essential for establishing cell polarity, 
directed cell migration, and maintaining cell growth and survival. 
 
1.4.1. Integrins and cell shape: the association of actin and integrins. 
Ligand binding to integrins leads to integrin clustering and recruitment of actin filaments and signalling 
proteins to the cytoplasmic domain of integrin. Actin cytoskeletal structures include cortical actin, stress 
fibers, lamellipodia, and microspikes. Actin stress fibers are linked to integrins at the inner surface of the 
plasma membrane involving a focal adhesion complex including α-actinin, Focal adhesion kinase, talin, 
vinculin, and zyxin. Signaling through integrins depends on the formation of these focal adhesions, 
dynamic sites in which cytoskeletal and other proteins are concentrated and which regulate migration and 
the shape of a cell.  
Remodelling of preexisting actin filaments into the different actin filaments structures is mainly controlled 
by members of the Rho family of GTPase. Among them, CDC42 induces filopodia, Rac induces 
lamellipodia, and Rho induces focal adhesions and associated stress fibers. It is known that integrins can 
activate the Rho-family of small guanine nucleotide –binding proteins and then regulate cell speading and 
migration (Ren X.D et al. 1999).  
It is well appreciated that alterations in ECM–integrin interactions cause changes in cell shape and 
behaviour. For example, TENASCIN-C, an extracellular matrix (ECM) glycoprotein, interacts with αvβ3 
integrins to modify smooth muscle cell shape (Jones PL et al. 1997). However, recent studies have 
demonstrated that ECM-dependent changes in cell shape and three-dimensional tissue architecture 
determine cell function by modulating integrin signalling pathways. For example, when cultured on an 
exogenous basement membrane, normal mammary epithelial cells adopt a polarized cuboidal morphology, 
become quiescent and express high levels of β-casein. Although expression of β-casein depends upon 
basement-membrane (BM) laminin interacting with β1 integrins and activation of a tyrosine 
phosphorylation signalling cascade, the rounding and clustering of the cell is also a necessary condition 
for the milk production; if mammary epithelial cells are forced to spread on laminin, while maintaining 
their interaction with β1 integrins, expression of β-casein is suppressed (Roskelley, C. 1994). Thus cell 
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shape could impact upon integrin-dependent signalling pathways and appears to profoundly modulate the 
processing of signals generated by identical ECM–integrin interactions. 
Recent work has revealed that the integrin–actin cytoskeleton connection is highly dynamic and subject to 
many regulatory processes. In healing skin wounds for example, integrin-mediated cues promote the 
reorganization of the cytoskeleton of keratinocytes at the wound edge resulting in directed migration and 
wound closure. Loss of ß1-integrins on keratinocytes leads to impaired as well as non-directed migration 
resulting in severely delayed re-epithelialization (Grose et al., 2002). Furthermore, it has become clear that 
the interaction between integrins and the actin cytoskeleton is differentially regulated in different locations 
of the cell. At the leading edge of migrating cells, integrins bind the ECM, recruit the actin cytoskeleton 
and initiate local reorganization of the actin network, promoting different types of membrane protrusion. 
At the rear of the cell, integrins detach from the ECM, dissolve the link to the cytoskeleton and are, at least 
partially, recycled to the front of the cell (Ballestrem et al., 2001). Taken together, these data indicate that 
the interaction of the cytoskeleton with the adhesion receptors plays an important role in cell polarity, 
spreading and motility. 
 
1.4.2. Integrins and cell cycle control 
1.4.2.1. Overview of cell cycle control mechanisms 
In the past decades extensive studies using cultured cells and genetic model organisms have strongly 
contributed to the elucidation of the mechanisms that regulate cell proliferation and the the cell cycle. A 
synopsis is given below. Basically, the cell cycle is divided into four phases: G1 (gap 1), S (DNA 
synthesis), G2 (gap2) and M (mitosis). The individual phases of the cell cycle allow for a controlled 
replication of the genome, organelles and other cellular components.  
Here we would like to discuss mainly the mechanisms regulating G1 to S phase progression on which my 
work has focused. Cyclins and cyclin dependent kinase (CDKs) are known to be major players in 
mediating the progression and passage through these two phases of the cycle. CDKs are inactive in the 
absence of their cyclin partners, and they are activated by the binding of their partner cyclins. In 
mammalian cells, the major complex present in G1 is Cyclin D/CDK (4 or 6). During the late G1 phase, 
Cyclin E is actively expressed and binds CDK2 forming the Cyclin E/CDK2 complex. Cyclin A is 
induced at or near the G1/S boundary; it binds to CDK2 in S phase and involved in S phase progression. 
In addition to their binding to Cyclins, the activity of CDKs is also regulated by the presence of Cyclin 
dependent kinase inhibitors (CKI).  
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Mitogenic growth factors promote G1 phase cell cycle progression by stimulating the formation or 
activation of Cyclin D-cdk4/6 and Cyclin E-cdk2. These mitogenic effects typically involve increases in 
Cyclin D expression and decreases in CKI expression. The active enzymes then phosphorylate the 
retinoblastoma protein (pRb) and its family member, p107. Hypophophorylated pRb and p107 form 
complexes with members of the E2F family, which act as transcriptional repressors. PRb and p107 
phosphorylation results in disruption of pRb/E2F and p107/E2F complexes, allowing for the induction of 
E2F dependent genes such as Cyclin A (DeGregori J.T; 1995). 
As we discussed above, CKIs are involved in the modulation of the CDK activity during the cell cycle. 
This family of proteins can be divided in two broad categories: cip/kip family (p21cip1, p27kip1, and 
p57kip2) which bind to cyclin E-cdk2, cyclin A –cdk2, and cyclin D-cdk4/6, and the INK4 family (p15, 
p16, p18, and p19) which bind only to cyclin D-cdk4/6. The members of the Ink4 group inhibit cdk4 and 
cdk6 by promoting their dissociation from Cyclin D, while the Cip/Kip members inhibit all CDKs in a 
concentration dependent manner (sherr, C.J, 1996). Overexpression of any member of the CIP/Kip family 
causes a G1 block/arrest in transfected cells; while overexpression of Ink4 members such as p16 causes a 
reduction of the Cyclin D/cdk4 complex levels (Quelle D.E.et al. 1995) 
The p21 and p27 proteins are necessary for the formation and stabilization of CyclinD/CDK4 complexes 
(Cheng, M., et al.,1999). The titration of these two CKI relieves the inhibition of Cyclin E/CDK2 
complexes. This, in turn, grants the progressive accumulation of Cyclin E/CDK2 activity and the further 
hyperphosphorylation of Rb proteins. The system generates a hierarchical program of CDK activation 
since the increase of CDK2 activity during G1 requires inactivation of both the cip/kip proteins and is 
therefore dependent on the prior activation of the Cyclin D pathway. Once CDK becomes active it triggers 
the degradation of p27 by targeting it for phosphorylation and subsequent ubiquitination (Vlach, JS 
Hennecke & B.Amati, 1997). This event has two major effects: The destabilization of Cyclin D/CDK(4,6) 
complexes and the resulting release of p21 which is able to inhibit Cyclin E/cdk2. The temporary titration 
of p21 by Cycline E/CDK2 allows the formation of CyclinA/CDK2 complexes, which will then mediate S 
phase progression. P21 and p27 differ mostly in their expression kinetics. Generally p27 levels are high in 
quiescent cells and decrease in late G1, the protein levels are thought to be regulated by proteasome 
mediated degradation (Vlach, JS Hennecke & B.Amati, 1997). P21 levels instead, are low in quiescent 
cells and increase during the late G1 phase (Macleod, KF et al. 1995). In addition to its normal regulatory 
mechanisms, p21 levels can be induced by the p53 pathway. The INK4 proteins are thought to mediate 
CDK activity modulation through the same pathway. Upon an anti-mitogenic stimulus, such as TGF-β, 
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INK4s are expressed and promot the dissociation of CyclinD/CDK4, which causes the releases of p21 and 
the inhibition of cdk2 activity (Reynisdottir,I. et al. 1995).  
 
1.4.2.2. Integrins and cell cycle control 
Integrins are required for growth factor signalling 
Cells require anchorage to the ECM to proliferate. Integrins activate growth-promoting signaling 
pathways that are responsible for the anchorage requirement. Two such pathways appear to be activated 
by most integrins. In one of them, integrins facilitate growth factor–mediated activation of ERK. In some 
cells, signaling along the Ras-ERK cascade is blocked at the level of the activation of either Raf or MEK 
in the absence of attachment. Integrins remove this block, perhaps by activating Rac or PI 3-kinase (Frost 
J.A., et al.1997). ERK may be required for cell growth because it phosphorylates the ternary complex 
factor (TCF), which promotes transcription of the immediate-early gene c-Fos (Treisman R., 1996). In 
another pathway, integrins activate the MAPK c-Jun NH2-terminal kinase (JNK), which regulates 
progression through the G1 phase of the cell cycle. The activation of JNK requires the association of FAK 
with Src and p130CAS and the recruitment of Crk (Miyamoto S, et al. 1995). Activated JNK enters the 
nucleus and phosphorylates the transcription factor c-Jun, which combines with c-Fos to form the AP-1 
transcription factor complex. AP-1 then regulates genes that are important for cell proliferation (Treisman 
R., 1996). Because most growth factors are poor activators of JNK, the ability of integrins to activate this 
kinase may explain why cell proliferation requires integrin-mediated adhesion. 
 
Integrins regulate cyclin-Cdk activity 
As we mentioned, progression through the G1 phase of the cell cycle requires the sequential activation of 
CDK4/6 and CDK2. The activities of these kinases are regulated by integrins. Thus, integrin signals are 
necessary for cells to traverse the cell division cycle. For example, the activation of CDK4/6 are 
suppressed in cells that are not anchored to ECM (Zhu X, et al., 1996). Moreover, anchorage to the ECM 
is necessary for the down-regulation of the CDK2 inhibitors p21 and p27 and, thus, activation of cyclin E–
CDK 2 (Zhu X, et al., 1996). The reason for the accumulation of p21 and p27 in suspended cells is not 
known, but its effect is compounded by the decrease in Cyclin D–CDK 4/6, a complex that sequesters p21 
and p27 and prevents their action on CDK2 (Giancotti FG & Ruoslahti E. 1999). 
A few studies have tried to link specific integrins with specific events in anchorage-dependent cell cycle 
progression. Symington (Symington BE. 1995) showed that CDK activity and pRb phosphorylation were 
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stimulated when a α5β1 integrin overexpressing K562-subclone was treated with the peptide GRGDS (a 
ligand for α5β1 integrin). Klekotka et al. showed that the α2β1 integrin supports cell-cycle progression of 
mammary epithelial cells adherent to type I collagen matrices. Integrin collagen receptors containing the 
α2 cytoplasmic domain stimulated expression of Cyclin E and CDK2 resulting in Cyclin E/CDK2 
activation in the absence of growth factors other than insulin (Klekotka PA et al. 2001). Meredith et al. 
(Meredith  et al. 1999) microinjected a growth inhibitory form of the β1-integrin subunit into 10T1/2 
fibroblasts and found that cell cycle progression was blocked in late G1, near or after the induction of 
cyclin E-CDK2 activity. Nevertheless, detailed studies of specific integrin on distinct Cyclin-CDK events 
have yet to be reported. 
 
1.4.3. Integrins and cell survive 
Apoptosis is an efficient way to physiologically eliminiate excess or damaged cells in a controlled manner 
that precludes an inflammatory response. Integrin-mediated cell attachment is one of the main regulators 
of apoptosis. Loss of attachment to the matrix causes apoptosis in many cell types. This phenomenon, 
referres to as “anoikis”, may help maintain the integrity of tissues. (Frisch and Screaton, 2001). Specific 
integrin mediated attachment plays an important role in suppressing anoikis. For example, upon 
detachment, HUVECs rapidly die by apoptosis. However, adhesion on fibronectin protect HUVECs from 
TNF induced cell death (Fornaro M et al. 2003). Also, a laminin-rich basement membrane is required for 
long-term cultures and survive of primary mammary epithelial cells (Farrelly N et al. 1999).  
Integrins suppress anoikis in attached cells by activating signaling pathways that promote survival and 
inactivating the ones that promote apoptosis. A number of these pathways have been partially 
characterized and seem to be of varying importance in different types of cells. A pathway that begins with 
the activation of focal adhesion kinase (FAK) by ECM bound integrins and results in the activation of 
phosphatidylinositol 3-kinase (PI3-K) and Akt/protein kinase B seems to be a major source of survival 
signals in most cells (Frisch et al. 1996b; Khwaja et al. 1997 and Matter and Ruoslahti, 2001). Akt 
promotes survival, at least in part, by phosphorylating and thereby inactivating two proapoptotic proteins, 
Bad and caspase-9 (Cardone et al.,1998 and del Peso et al. 1997). Inhibition of p53 prevents FAK 
deficient cells from undergoing anoikis when deprived of growth factors, suggesting that p53 mediates the 
death signal under FAK deficiency (Ilic D, et al. 1998).  
Like cell growth, anoikis can be controlled by the ECM in an integrin-specific manner. The α5β1 and 
αvβ3 integrins induce expression of the anti-apoptotic protein Bcl-2 in CHO cells, protecting cells from 
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apoptosis from stresses such as the lack of growth factors. Other integrins, including another fibronectin 
receptor, αvβ1, do not provide this survival effect. (Zhang et al. 1995; and Matter and Ruoslahti, 2001). 
Using truncated Bcl-2-regulating integrin (α5β1) screening (the cytoplasmic domain of the Bcl-2-
regulating integrin was truncated to screen for cDNAs capable of enhancing expression of the Bcl-2 gene 
despite the disabled integrin), a mitochondrial protein, Bit1, was identified that is released into the 
cytoplasm during anoikis and to mediates apoptosis by regulating the functions of two Groucho family 
transcriptional regulators : AES and TEL. Importantly, the apoptosis induced by Bit1/AES is atypical in 
that caspase activation is not involved.(Jan,YW, et al. 2004). In addition, the αvβ3 integrin promotes 
endothelial and melanoma cell survival; this effect correlates with suppression of the p53 pathway and 
activation of the nuclear factor kappa B transcription factor (Stromblad S et al. 1996 & Scatena, M et al. 
1998). The activation of Shc by α1β1, α5β1, and αvβ3 may also contribute to protection from apoptosis 
(Wary KK, et al. 1996). Furthermore, integrins and the EGF receptor coordinately prevent anoikis in 
epithelial cells by downregulating the BH3 domain-only proapoptotic protein Bim (Reginato et al., 2003). 
Thus, integrin mediated attachment to ECM is a general requirement for cell survival, but survival under 
special circumstances may require a particular integrin.  
Anoikis is likely to be important in the maintenance of tissue architecture, as it would ensure the demise of 
cells that detach from their original site in a tissue. The requirement for a specific integrin as the mediator 
of the attachment may provide an additional safety factor, because it would facilitate the destruction of 
cells that have attached at an inappropriate tissue location. Tumor cells are generally resistant to anoikis 
and can proliferate in the absence of anchorage to ECM (Schlaepfer & Hunter, 1998). This may help to 
explain their propensity to leave their original site and metastasize. 
 
1.5. Functional consequence of integrin gene mutations in mice 
 
During the last two decades, most of the information about integrin function has been derived from in 
vitro cell culture systems. Gene targeting technology recently made it possible to generate mice that lack 
specific integrins in a constitutive or cell type-specific manner. Analyses of these mice demonstrate how 
integrin-mediated adhesion and signal transduction affect development and maintenance of tissues and 
provide additional insight into integrin functions in various diseases. 
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To date, 18 α and 8 β integrin subunits have been deleted in the mouse. Ablation of integrin genes leads to 
various phenotypes during mouse development, ranging from apparently normal mice to early lethality 
(Bouvard D, et al. 2001). β1 integrin is the most widely expressed integrin and controls various 
developmental processes. In this chapter, we will mainly focus on integrin β1 and discuss its role in early 
mouse development and in the different development contexts.  
 
1.5.1 Early mouse development 
Disruption of the ubiquitously expressed integrin β1 gene leads to the loss of at least 12 different integrin 
receptors and results in peri-implantation lethality characterized by an inner cell mass (ICM) failure. 
Fertilization of β1-null oocytes and the entire pre-implantation development is normal (Fässler & Meyer, 
1995; Stephens LE et al. 1995). A possible explanation of the ICM failure could be the loss of β1-
mediated survival signals since lack of interaction of the ectodermal cells with the BM could lead to their 
loss by apoptosis and arrest of additional development (Coucouvanis & Martin, 1995). Another possibility 
could be that the lack of β1 integrins leads to abnormal BM assembly since β1 integrin is crucial for 
normal expression and correct assembly of BM components into a supramolecular structure (Aumailley M 
et al. 2000). 
 
1.5.2. Neurogenesis 
Evidence coming from fly and worm suggest a critical role for the integrin family during brain 
development and for maintaining brain functions (Anton ES et al. 1999). This was also confirmed in mice. 
α3-null mice display a defect in neuron migration and a disorganized layering of the cerebral cortex, 
suggesting that this integrin is involved in radial neuronal cell migration. A very similar phenotype is 
observed in reeler mice, which lack the extracellular matrix protein reelin. In these mutant mice, migration 
of Cajal-Retzius cells is impaired, leading to an abnormal lamination of the cerebral cortex. A recent study 
showed that α3β1 integrin can bind reelin (Dulabon L et al. 2000). This interaction may provide a stop 
signal and arrest neuronal migration. Ablation of the β1 integrin gene in all cells of the developing cortex 
causes cortical neurons to become severely disorganized and Cajal-Retzius cells misplaced, but does not 
prevent the migration of neuronal precursors, however, it does cause layering defects close to the marginal 
zone (Graus-Porta D, 2001). The ability of neuronal precursors to migrate in the absence of β1 integrin is 
not consistent with the migration phenotype seen in the absence of the α3 integrin, since β1 is the only 
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subunit that is known to form heterodimers with α3. Perhaps an altered balance between different β1 
integrin heterodimers is more detrimental than their complete absence. 
Myelination in the peripheral nervous system is accomplished by Schwann cells. Myelin-forming 
Schwann cells synthesize abundantly the laminin receptors α6β4, α6β1 integrins and dystroglycan, and 
minor amounts of α2β1 integrin. Inactivation of β1 integrin specifically in Schwann cells using the Cre-
loxP system has shown that β1 integrins are crucially important for Schwann cell–axon interactions. β1-
null Schwann cells populates nerves, proliferate, and survive normally. However, loss of 
integrin β1 causes failure of ensheathing and segregating axons in development nerves 
and delayed myelination. (Feltri ML et al. 2002). 
 
1.5.3. Chondrogenesis 
β1 integrin is a dominant integrin β subunit expressed in the heart. Two of the four splice variants of 
β1 integrin; β1A and β1D are expressed on cardiac myocytes. They are identical with the exception of the 
last 24 amino acid residues of their respective cytoplasmic domains. The expression of β1A and β1D 
isoforms is developmentally regulated in cardiac cells. β1A is expressed during embryogenesis while β1D 
expression begins late in development and eventually becomes the dominant β1 integrin isoform 
expressed on adult cardiac myocytes. On the basis of in vitro analysis, integrin-mediated attachment to the 
ECM has been suggested to be important for controlling growth and differentiation of cardiomyocyte 
(Borg TK et al. 2000). Furthermore, integrins were proposed to function as mechanoreceptors that 
transform mechanical stimuli into biochemical signals that affect cellular function (Borg TK et al 2000). 
Several genetic mouse models demonstrate an important function of β1 integrin in cardiac muscle in vivo. 
Mice expressing β1A instead of β1D in heart show a mildly disturbed heart phenotype, whereas 
replacement of β1A by β1D results in embryonic lethality with a plethora of developmental defects, in part 
caused by the abnormal migration of neuroepithelial cells. (Baudoin C et al. 1998). Even more severe 
defects occur in the heart when both β1A and β1D are absent or functionally inactivated. The areas with 
β1-null cardiac muscle cells in the heart of β1-null chimeras become smaller with time and show signs of 
degeneration. Ultra-structural analysis revealed alterations in the sarcomeric architecture. In addition, 
transgenic mice expressing a dominant-negative form of β1 integrin, in which the extracellular and 
transmembrane domain of CD4 is fused to the cytoplasmic domain of β1 integrin, show hypertrophic 
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changes in the heart. Mice that express high levels of the transgene die around birth and display a 
replacement fibrosis (Keller RS et al. 2001).  
 
1.5.4. Skin and hair follicle morphogenesis 
The skin is composed of an epidermal and a dermal layer, which are separated by a basement membrane. 
The epidermis is made primarily of keratinocytes, while the dermis contains different cell types including 
fibroblasts, endothelial cells and macrophages as well as large amounts of extracellular matrix. Adhesion 
of the keratinocytes to the basement membrane and to each other is important for the development of skin 
and for the maintenance of skin integrity. During differentiation, basal keratinocytes detach from the 
basement membrane and migrate to suprabasal layers. This movement is accompanied by a complex 
change of cell–cell and cell–matrix interactions involving adhesion molecules such as cadherins and 
integrins (Hotchin et al., 1995; Zhu and Watt, 1996). Basal keratinocytes attach to the underlying 
basement membrane via integrins. In skin, several integrin receptors are expressed by the epidermal 
keratinocytes, including α2β1, α3β1 and α6β4. Genetic ablation of the α6 or β4 integrin gene in mice 
resulted in a complete absence of hemidesmosomes, creating large blisters between the dermis and the 
epidermis (Georges-Labouesse et al., 1996; van der Neut et al., 1996). Skin-specific ablation of the 
β1 integrin gene at around birth demonstrated a role of β1 integrin in the processing of the BM 
components and in the growth and maintenance of hair follicles. β1-deficient basal keratinocytes have an 
aberrant morphology and a reduced proliferation rate, but are still able to terminally differentiate. While 
ectopic expression of α2, α5 and β1 integrin in the suprabasal layers of transgenic mice resulted in 
hyperproliferation, perturbed keratinocyte differentiation and a psoriasis-like phenotype (Carroll et al., 
1995). 
 
1.5.5. Myoblast fusion 
Vertebrate skeletal muscle fibers express many integrin subunits in developmentally regulated patterns, 
including the integrin β1 subunit and its partners α 1, 3, 4, 5, 6, 7, and  (Gullberg et al., 1998). The most 
abundant integrin in skeletal muscle is α7β1, which is expressed during all stages of muscle development 
(Bao ZZ et al. 1993). Mice with a targeted deletion of the α7 integrin develop a progressive muscular 
dystrophy after birth. The major defect is severe disruption of the myotendinous junctions (Mayer et al., 
1997). Mutations that inactivated the mouse integrin β1 subunit gene in developing myoblasts show that 
β1 integrins regulate myoblast fusion and sarcomere assembly. β1-deficient myoblasts adhere to each 
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other, but plasma membrane breakdown is defective. The integrin-associated tetraspanin CD9 that 
regulates cell fusion is no longer expressed at the cell surface of β1-deficient myoblasts, suggesting that 
β1 integrins regulate the formation of a protein complex important for fusion. Subsequent to fusion, β1 
integrins are required for the assembly of sarcomeres. Other ECM receptors such as the dystrophin 
glycoprotein complex are still expressed but cannot compensate for the loss of β1 integrins, providing 
evidence that different ECM receptors have non-redundant functions in skeletal muscle fibers 
(Schwander.M et al 2003). 
 
 
 
 24
  
 
Part II Mammary gland development 
 
2.1 Mammary gland is an attractive organ for development studies 
 
Mammary gland is a specific organ for female mammals. This developed organ could deliver essential 
nutrients to the newborn offspring. These nutrients are assembled in a rich proteinaceous and lipid fluid 
termed milk. Milk is sufficiently complex that it alone is sufficient to support the development of the 
newborn through the critical initial stages of postnatal development and growth. Functional differentiation 
of the mammary gland is a crucial step in the reproductive cycle of mammals. The anatomical and 
morphological design of the gland as well as the regulation of its development and function is subservient 
to this main function. 
The mammary gland consists of two primary components: the parenchyma, which forms a system of 
branching ducts from which secretory acini develop, and the adipose stroma, which provides a substrate 
within which the parenchyma develops and function. The parenchyma consists of two major epithelial 
structures: collecting ducts that form during puberty and are maintained throughout adulthood, and alveoli, 
containing the luminal, milk-secreting cells that appear during pregnancy and lactation and are lost during 
remodeling at involution. Alveolar growth and proliferation occurs predominantly during pregnancy, 
followed by functional differentiation of alveolar epithelial cells at parturition. Some additional alveolar 
proliferation occurs during the first few days of lactation. During lactation, the secretory cells produce 
large amounts of milk.  
Human breasts begin developing in the embryo. In both female and male newborns, milk ducts and 
lobules (milk producing glands) are well formed and organized. With the beginning of female puberty, 
the release of estrogen in combination with progesterone causes the female breasts to undergo dramatic 
changes, which culminate in the fully mature form. Further maturation of the breast tissues occurs with 
lactation. 
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and function of mammary gland is an important event for the reproduction of the mammals. Furthermore, 
the understanding of normal gland function, development, structure and regulation can assist the 
investigation of the breast cancer; a disease threatens the females, for example, 180,000 woman annually 
in the United States. Finally, the mammary gland is a good model for the development studies when the 
repeated phases of growth and differentiation can be examined, since at involution the organ goes through 
complete remodeling. Thus the mammary gland provides a unique opportunity to evaluate the role of 
specific proteins in the formation and function of a transient, but highly specialized, organ. Also, in 
mammary gland, the complex biological and cellular interactions make the possibility to study the 
regulation of the same gene expression in diverse cell types.  
 
2.2 The development of mammary epithelium 
The mammary gland consists of two major epithelial structures: collecting ducts that form during puberty 
and are maintained throughout adulthood, and alveoli, containing the luminal, milk-secreting cells that 
appear during pregnancy and lactation and are lost during remodeling at involution. 
 
2.2.1.Terminal end bud formation and ductal morphogenesis. 
A branched epithelial structure includes a network of tubes that are integral to the function of a number of 
glandular organs (Gumbiner BM, 1992; Affolter M, et al 2003). Lung, kidney, salivary gland , and 
mammary gland are examples of organs that develop through branching morphogenesis. The latter is 
unique among these organs in that the majority of its branching is post-embryonic. Extensive branching 
begins in puberty in the female and ceases after expanding to the outer limits of the mesenchymal fat pad.  
Branched structures are first seen in the mouse mammary gland in late embryonic development 
(Robinson GW et al , 1999). Expansion of the ductal tree within the fat pad occurs rapidly after 3 to 4 
weeks of age, when ovarian hormones begin systemic circulation, and ceases around 10 weeks of age. 
During branching morphogenesis, primary ducts elongate, driven by terminal end bud proliferation, and 
the tree 'fans out' within the fat pad through a process of terminal end bud bifurcation and lateral side 
branching.  
Mammary ducts are composed of a mixture of epithelial cells with distinct morphological and function 
lineages: the luminal cells, which form the tubular duct; and the second lineage, which give rise to 
myoepithelial cells to aid in the expulsion of milk from the alveoli during lactation. Both of these lineages 
are established simultaneously and arise from the end buds during puberty (Williams and Daniel, 1983). 
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The teminal end buds are bulbous structures found in pubertal animals. Elongation of mammary ducts in 
the immature mouse takes place as a result of rapid growth in end buds. These structures proliferate at the 
apex of elongating ducts and are responsible for penetration of the surrounding adipose stroma; by turning 
and branching, end buds give rise to the characteristic open pattern of the mammary ductal tree.  
These bulb-shaped structures consist predominantly of an outer layer of epithelial cells, termed cap cells, 
and an inner layer of epithelial cells, termed body cells. The extent of proliferation in the TEB has been 
estimated to be as much as 5-fold more than that observed in mature ducts. Within the TEB, the cap cells 
often display the highest proliferative activity (Dulbecco R,1982, Humphreys RC 1999). The TEB is also 
a site of significant apoptosis in the developing gland, and it is this apoptosis that is believed to cause 
canalization of the developing ducts (Humphreys RC,1996). Regulation of TEB development occurs at 
several levels involving steroid and peptide hormones as well as local production of growth factors 
(Humphreys RC 1999, Kleinberg DL 1997)
Numerous studies suggest that IGF-I plays an important role in mammary gland development. Firstly, 
IGF-I is a potent mitogen for normal mammary epithelial cells in culture, and ductal growth can be 
induced in mammary gland explant cultures by IGF-I in combination with mammogenic hormones 
(Richert M, Wood TL 1999). Secondly, in vivo local administration of IGF-I induces mammary TEB 
development (Kleinberg DL 1998) and transgenic mice that overexpress IGF-I specifically in the 
mammary gland during pregnancy and lactation exhibit an increased incidence of mammary hyperplasia 
and tumorigenesis (Hadsell DL, 1996 & 2000). Lastly, the mRNAs for both IGF-I and the IGF-I receptor 
(IGF-IR) are expressed in both the mammary stroma (Walden PD, 1998) and the developing TEB (Richert 
M, Wood TL 1999), and studies by Ruan and co-workers (Ruan W & Kleinberg DL 2000) demonstrated 
that targeted deletion of IGF-I inhibits normal TEB development. 
Besides hormone and growth factors, it was found that the Matrix metalloproteinases (MMPs), the 
stromal factors that are ideally positioned to regulate stromal–epithelial cross talk (Sternlicht & Werb, 
2001), could regulate mammary gland branching morphogenesis by clearing a path for invading ducts by 
degrading ECM barriers and permitting ductal penetration into the mammary fat pad. During early 
puberty, MMP-2 supports the invasion of TEBs into the stromal fat pad, by protecting against excessive 
apoptosis within TEBs. Later in puberty, MMP-2 acts on the mature primary duct to repress excessive 
secondary lateral budding and branching. While MMP-3 acts on both primary and secondary ducts to 
induce secondary and tertiary branch formation (Bryony S, et al, 2003). In contrast, introduction of 
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exogenous tissue inhibitor of metalloproteinases-1 (TIMP-1) into pubertal mammary gland, via a pellet, 
retards ductal invasion (Fata et al., 1999). 
 
2.2.2 Alveolar development and milk secretion 
With pregnancy occurs, the gland begins forming side buds. Buds repeatedly form and elongate 
perpendicular to existing ducts to form small terminal ducts. When the mammary fat pad is filled so that 
there is little space between nascent buds, sac-like alveoli are formed at the end of the terminal ducts. 
Alveolar growth and proliferation occurs predominantly during pregnancy, followed by functional 
differentiation of alveolar epithelial cells at parturition. Some additional alveolar proliferation occurs 
during the first few days of lactation. It’s was demonstrated that prolactin induced phosphorylation of 
Stat5 is a key event in functional mammary development and differentiation. (Details will be discussed in 
2.2.5.2) 
The alveoli composed of a single layer of polarized luminal, milk-secreting cells that surround an 
enclosed space, or lumen. The earliest signs of lumen formation are many small cavities and crevices 
lined with microvilli which appear at scattered sites throughout the branching cords and neck of the gland. 
Differentiated luminal secretory cells are well polarized and organized. The myoepithelial, another cell 
lineage to basket the secretory cells in the alveolus, play central role in milk ejection. Differentiated 
myoepithelial cells are highly contractile and their ultrastructure is reminiscent of that of smooth muscle 
cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 Fig.7.The phenotype of mammary alveolar epithelium in
mouse. The spherical mammary alveolus, consisting of a
single layer of secretory cells, is shown in schematic cross-
section. Some important architectural and functional features
of this structure are: (1,2) extensive interactions between cells
and (1) ECM, as well as (2) other cells; (3) basal nuclei and
(4) apical microvilliindicating morphological polarity;
(5)casein microvilli and (6) fat droplets formed intracellularly
and secreted apically into the lumen; (7) myoepithelial cells
and their processes; (8) secreted milk is collected in ducts.29
At the end of pregnancy, the mammary gland starts milk synthesis. Milk is an externally secreted fluid 
designed specifically to nourish the young. It contains vital nutrients such as proteins, carbohydrates, 
lipids, minerals, and vitamins together with bioactive substances. Milk is secreted more or less 
continuously into the alveolar lumens and stored there. Removal of milk from the alveoli is accomplished 
by contraction of the myoepithelial cells surrounding the alveoli and ducts. This process is called milk 
ejection. 
 Most protein components are secreted from the mammary epithelium by exocytosis. In contrast, the lipid 
droplets bulge against and gradually become enveloped in apical plasma membrane, finally separating 
from the cell as the milk fat globule. By specific gene ablation, it was found that Xanthine oxidoreductase 
(XOR, the rate-limiting enzyme in purine catabolism is specifically required for enveloping milk fat 
droplets with the apical plasma membrane prior to secretion from the lactating mammary gland. The 
XOR+/- females are unable to maintain lactation and their pups die of starvation 2 wk postpartum 
(Claudia Vorbach, 2002). 
 
2.2.3 Involution    
Lactogenesis represents a profound and rapid series of changes in the activity of differentiated mammary 
epithelial cells from a quiescent state to a fully active secretory state. In the absence of suckling or at 
cessation of nursing, these differentiated mammary epithelial cells are removed and the gland is 
remodeled to a duct system similar to that in the mature virgin. This process, named as involution, is the 
last stage of the mammary life cycle. The destroyed milk-producing machinery can be recapitulated in a 
subsequent pregnancy in preparation for another round of lactation. 
Mammary gland involution goes through two distinct stages. In the first stage, lack of suckling and milk 
stasis results in a rapid, but reversible induction of apoptosis within the differentiated population of 
mammary epithelial cells, but there is no remodeling of the lobular-alveolar structure. When the lack of 
suckling is prolonged, the involution goes through into the second stage. The apoptosis is accompanied by 
a tissue-remodeling phase involving the induction of matrix-degrading enzymes and inflammatory cell 
infiltration. The lobular-alveolar structure of the gland is obliterated as proteinases degrade basement 
membrane and extracellular matrix (ECM). This mammary alveoli regress process cannot be reversed. 
The end result of this process is the elimination of all lobuloalveolar structures leaving behind a simple 
ductal tree. 
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In mice, apoptosis of mammary alveolar cells commences within hours of the end of sucking and peeks at 
day 3 and decreases thereafter, while the alveolar structure has completely degenerated after a dying 
period of 4 days. The apoptosis of individual alveolar cells is correlated with increased expression levels 
of many genes. It was found stat3, another member of the STAT family of proteins, was induced in the 
first phase of involution. And the mice of conditional knock out of stat3 in mouse mammary gland 
showed a decrease in epithelial apoptosis and a dramatic delay of the involution process upon forced 
weaning (Chapman RS, 2000). 
 
2.2.4 Hormonal and growth factor regulation 
Development of the mammary gland is controlled by systemic steroid and peptide hormones and local 
growth modulators (Topper and Freeman, 1980). Steroid hormones of the ovary and placenta were 
implicated very early as important stimulators of mammary gland development (Anderson R, 1974). The 
ductal outgrowth and, in part, alveolar proliferation is controlled by ovarian steroid hormones (Daniel and 
silberstein 1987). It was already determined that estrogen stimulates ductal elongation (Korach et al, 
1996), while progesterone is necessary for alveolar development (Humphreys et al. 1997). Furthermore, It 
was established that prolactin (PRL), a 23-kDa peptide, which is mainly synthesized in lactotrophic cells 
of the anterior pituitary of vertebrates, are involved in lobuloalveolar differentiation, milk synthesis, and 
lactation (Topper and Freeman, 1980). Prolactin is essential for the transition from a proliferative to a 
lactating mammary gland and for the maintenance of milk secretion. The withdrawal of prolactin and 
oxytocin, another peptide hormone inducing the contraction of myoepithelial cells and thereby for milk 
ejection, causes involution of the mammary gland to a mature virgin-like state (Wagner, 1997).  
Additionally, A stimulatory role in the proliferation and/or differentiation of mammary epithelial cells is 
suggested for most growth factors including epidermal growth factor, amphiregulin, transforming growth 
factor, and insulin like growth factor (Lamote.I ,2004). 
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ecline after the mitogens have been removed. This, together with a very short half-life of this protein 
lin D1 levels in response to changes in extracellular environment (Sherr, 
 as an oncogene responsible for parathyroid adenomas 
 Consistent with the oncogenic role of cyclin D1 are the observation that transgenic 
Fig.8. Overview of the regulation of mammary gland development. During embryonic development, signaling 
molecules important in epithelial-mesenchymal interactions include PTHrP, FGF-10, LEF-1, and Msx2. Under the 
influence of maternal PRL and PL, the neonatal mammary gland undergoes transient functional differentiation and 
 
 
 produces witch's milk. Mammary gland development proceeds slowly after birth until puberty, when E and GH 
stimulate rapid ductal elongation. During pregnancy, progesterone stimulates alveologenesis and lactogenesis 1. At 
parturition, the withdrawal of progesterone is required for initiation of lactogenesis 2. Prolactin promotes lactogenesis 2 
and, along with oxytocin, maintains lactation. The withdrawal of prolactin and oxytocin causes involution of the 
mammary gland to a mature virgin-like state. (MFP, mammar.y fat pad; TEB, terminal end bud.) Wysolmerski; 
endotext.com 
 
 
 
 
 
2 2.5. Signaling within the cell 
.5.1. Proliferation and Cell cycle regulators 
 the first chapter (1.4.2), we already discussed the cell growth and cell cycle control. It’s known th
clins and cyclin dependent kinase (cdks) are the major players in mediating the progression and passa
rough the cycle.  
ur mammalian G1 cyclins have been described to date: cyclins D1, D2, D3 and cyclin E. Th
pression of cyclin D1 is rapidly induced following the exposure of cells to mitogens; it's levels rapi
2
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c
th
F
e
d
permits rapid modulation of cyc
C.J. 1994). Cyclin D1 was originally cloned
(Motokura et al. 1991). Subsequently, the aberrant expression of cyclin D1 was documented in several 
human malignancies. Most striking is the frequent involvement of cyclin D1 in human breast cancers 
(Schmidt, E. 1996).
mice engineered to overexpress this cyclin in their breast tissue are prone to mammary adenocarcinomas 
(Wang, T.C. et al. 1994). 
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Besides basic cell cycle machinery modulators, there is an increasing list of local growth factors, such as 
epidermal growth factor, amphiregulin, and insulin like growth factor, has been shown to have a 
stimulatory role in the proliferation and/or differentiation of mammary epithelial cells. Mammary glands 
from adolescent AR null mice displayed striking defects in ductal outgrowth. Additional loss of EGF or 
TGF exacerbated the defect whereas mice lacking only EGF and TGF had normal glandular arborization, 
underscoring the fundamental role of AR in ductal elongation (N. Luetteke et al, 1999). Different from 
EGF ligand, studies in mice on ERBB expression and activating profiles revealed that signalling by 
on of receptors. Receptor-
ssociated tyrosine kinase (JAKs) cross-phosphorylate each other as well as the tyrosine residues on the 
toplasmic proteins from the STAT family are recruited 
tional postpartum gland, high levels of activated Stat5 can be found while only small amounts 
EGFR is critical for ductal outgrowth(L. Troyer and D. Lee, 2001). The insulin-like growth factor (IGF) 
family of ligands (IGF-I and IGF-II), binding proteins (IGFBP 1–6), and receptors (IGF-IR and IGF-IIR) 
also play pivotal roles in growth and development of the mammary gland. And the downstream signalling 
pathways of IGF receptors have been elucidated. In general, IGF-IR acts through two primary cascades, 
the mitogen activated protein (MAP) kinase and phosphatidyl-3-kinase (PI3-K) kinase pathways. The 
ultimate targets of the MAP kinase and PI3-K kinase cascades include members of the Ets and forkhead 
transcription factor families. Regulation of transcription factors provides a mechanism by which IGF 
mediates a proliferative and differentiative effect (LeRoith and Roberts, 2003). 
 
2.2.5.2 cell differentiation and Stat5a regulation. 
During lactation, the secretory cells produce large amounts of milk. Inside the various milk proteins, 
WAP and β-casein are as known to be transcriptional regulated by prolactin-JAK-STAT signalling 
pathway. 
Prolactin and many cytokins use STAT proteins to regulate the transcriptions of specific genes through 
the JAK-STAT pathway. Ligand binding triggers dimerization or oliogmerizati
a
receptors. Subsequently, SH2-containing latent cy
to the receptor complex and phosphorylated by the JAKs. Two STAT proteins dimerize, translocate into 
the nucleus, and activate gene transcription by binding to GAS in gene promoters. 
In the func
of phosphorylated Stat1 and Stat3 have been detected (Liu, X., 1996). And phosphorylation of Stat5a and 
-5b is very low in mammary tissue of virgins and during early pregnancy but rises sharply after day 14 of 
pregnancy. This led to the hypothesis that the activation of Stat5 is a critical step in the terminal 
differentiation of mammary secretory epithelium (Liu, X., 1996). 
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Indeed, the essential role of prolactin or STAT5 a as 
confirmed in mice by genetic disruptions in mice. The 
(Ormandy et al., 1997) or the Stat5a gene (Liu et 98) 
results in impaired alveolar proliferation and functi
Similar to the prolactin receptor, it was found that n to 
activate STAT5 (Jones et al., 1999; Kloth et al., rylates 
STAT5A at the regulatory amino acid Y694 in a STAT5A SRC-homology 2 (SH2) domain-dependent 
ctivation in Erbb4Flox/FloxWap-Cre 
ammary gland. PRL Fig.9. Prolactin signalling in the m
binds to its receptor and causes the PRLR to dimerize. 
Receptor-associated tyrosine kinase JAK2 phophorylates 
the prolactin receptor and the signal transducers and 
activators of transcription Stat5a and Stat5b. Activated 
Stat5a and –5b are transported into the nucleus, bind to 
GAS sequences and induce transcription of target genes. 
ctivity in mammary development and lactogenesis w
inactivation of either the prolactin receptor gene 
 al., 1997, Miyoshi et al., 2001; Teglund et al., 19
onal differentiation. 
members of the ERBB family have also been show
2002; Olayioye et al., 2001). ERBB4 phospho
manner (Jones et al., 1999). Furthermore, ERBB4 phosphorylates STAT5A at a tyrosine(s) in addition to 
at Y694 (Jones et al., 1999) raising the intriguing possibility that ERBB4 regulates novel STAT5 activities 
through multiple phosphorylation events. Recently, genetic ablation of Erbb4 alleles within the 
developing mammary gland revealed a complete ablation of STAT5 a
mammary epithelium at parturition. Consistent with disrupted STAT5 function, Erbb4Flox/FloxWap-Cre 
mammary glands at parturition failed to express the mammary epithelial differentiation marker Npt2B. 
Defects in epithelial functional differentiation at parturition were accompanied by a profound reduction in 
expression of the STAT5-regulated milk genes β casein and whey acidic protein. That suggests ERBB4 
functions as an essential mediator of STAT5 signaling, and that loss of STAT5 activity contributes to the 
impaired functional differentiation of mammary glands observed in mice containing conditional Erbb4 
deletions (Weiwen Long, 2003). 
  
2.2.5.3 Involution and apoptosis of mammary epithelia cells 
The two stages of mammary gland involution are controlled by progressive gain of death signals and loss 
of survival factors. The first stage of involution is controlled by local mammary-derived signals. Milk 
accumulation triggers increased expression of the death-inducing bax gene through a yet-undefined 
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mechanism. Importantly, this process is p53-independent (Li, M, 1996).  The same stimuli mediate loss of 
Stat5a and 5b phosphorylation disrupting the principal pathway for prolactin signaling (Schmitt-Ney, M, 
92; Liu X, 1996). Prolactin is a lactogenic hormone that can promote cell survival. Phosphorylation of 
first stage of involution at a time when Stat5 
ng remodeled (Lund, L. R, 1996; Boudreau, N, 1995). For example, 
19
Stat3 is low during lactation and increases sharply during the 
phosphorylation is lost (Liu.X, 1996). 
The second stage of involution is ushered in by the complete loss of survival factors due to decreased 
levels of systemic lactogenic hormones and activation of proteinase-dependent pathways (Lund, L. R, 
1996). Ensuing disruption of basement membrane and extracellular matrix (ECM) results in remodeling 
of the gland to a state resembling the mature virgin. Systemic lactogenic hormones are survival factors 
that persist through the first stage of mammary gland involution. Although these survival factors cannot 
overcome the dominant local apoptosis signals unleashed after removal of the suckling stimulus, they 
presumably prevent the gland from bei
glucocorticoid stimulation prevented progression of the gland into the second irreversible stage of 
involution, but did not block apoptosis (Li M.L 1997). Importantly, involution can be readily reversed 
during the first 48 h of involution, but not later. 
 
2.3 The function of mammary stromal. 
 
The essential functional component of mammary gland is the mammary epithelial cells. This cell is the 
one that synthesizes milk proteins and can occastionally become neoplastic. However, it relies on other 
cell types for its development and function. The mammary gland exsits as a community of epithelial cells 
that form adhesive interactions with extracellular matrix and the stromal cells. Such associations are 
ssential for maintaining normal tissue homeostasis and function, and, when they break down; cells are e
often deleted by apoptosis. 
 
2.3.1. Role of the stroma cells in the mammary development 
The stroma is an important primary component of the mammary gland. Breast stroma accounts for more 
than 80% of the resting breast volume (Drife JO, 1986). The stromal provides a substrate within which 
the parenchyma develops and function. And it can further support subsequent mammary parenchyma 
development. The stroma or the supportive platform for the epithelial layer is composed of fibroblasts, 
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endothelial cells, smooth muscle cells, adipocytes, inflammatory cells, nerve cells and a macromolecular 
ed the extracellular matrix (ECM).  
chymal 
re detected in stroma at a stage preceding ductal outgrowth (Webber-Hall et al. 1994) 
llagen IV, have been detected by immunohistochemistry 
round the ducts and alveoli of the virgin, pregnant, and lactating mouse mammary gland (Warburton et 
l., 1993; Keely et al., 1995). All of these components 
network of proteoglycans and glycoproteins collectively term
In seminal experiments by Kratochwil and Sakakura, it was suggested that the stroma play an active role 
in mammary gland development and function. It could direct and constrain the developmental plasticity 
of mammary parenchyma (Sakakura T, 1991). When Kratochwil cultured a composite of embryonic 
mammary epithelium and embryonic sub-mandibular (salivary) mesenchyme, the mammary tissue 
developed salivary gland-like lobules. Extending these experiments in vivo, Sakakura demonstrated that 
not only embryonic but also adult mammary tissue could respond in this way to salivary mesen
signals. Importantly, the instructive properties of the stroma did not extend to cytodifferentiation: in a 
pregnant host animal, salivary-like mammary transplants synthesized the milk protein α-lactal-bumin. 
(Sakakura T, 1976) 
The inductive role of stroma is evidence by the identification and elucidation of paracrine factors, which 
regulate the mammary parenchyma morphogenesis, e.g., Wnt proteins, transforming growth factor β 
(TGFβ), and hepatocyte growth factor. For example, TGF-β1 and TGF-β3 have roles in both promotion 
and inhibition of branching morphogenesis that are dependent on concentration and context. HGF/SF 
promotes ductal outgrowth and tubule formation in the mammary gland (Pollard JW. 2001). And Wnt-2, 
Wnt5a, and Wnt-6 a
rasing the possibility that one or more Wnt family are candidates for mediating epithelial induction by the 
stroma. It’s likely that additional paracreine factors will be identified as more attention is focused on role 
of the stroma. It is likely that further knowledge of stromal-epithelial interactions would greatly enhance 
the understanding of mammary gland function. 
 
2.3.2 cell–matrix interactions with the host stroma 
At the mammary epithelial and stromal cells boundary, there is a separating barrier of special ECM called 
basement membrane (BM). It contains various cellular elements such as laminin, fibrous and non-fibrous 
collagens, proteoglycans, and glycoproteins. The components of basement membrane, including LM-1, 
nidogen, heparan sulphate proteoglycan, and co
a
al., 1982, 1984; Sonnenberg et al., 1986; Beck et a
provide mechanical support to the tissue as well as forming a dynamic, developmentally active 
extracellular matrix/basal lamina complex. 
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An intact basement membrane is essential for the proper function, differentiation and survive of the 
mammary epithelial cells. For example, in the adult, evidence from culture studies show that the signals 
required for the induction of tissue-specific differentiation during pregnancy and maintenance of function 
during lactation arise primarily from basement membrane. Further support for a critical role for basement 
membrane in the functional differentiation of the gland comes from studies in involution where 
degradative loss of basement membranes correlates with loss of functional activity in the epithelium. 
 Howe, 1998). Furthermore, the 
Thus the extracellular matrix in conjunction with certain cytokines plays a central role in coordinating 
mammary epithelial development (Bissell MJ, 1993). Furthermore, it’s already established from cell 
culture model that ECM has an essential function in the control of mammary epithelial cell differentiation 
and survive. Primary mammary epithelial cells that fail to contact the BM show various alterations, 
including changes in survival and functional differentiation, as measured by their inability to respond to 
lactogenic hormones (Barcellos-Hoff et al., 1989) During involution, besides of apoptosis of epithelial 
cells, an important additional feature is the proteolytical degradation of the basement membrane between 
stroma and epithelium. Ultrastructural studies have demonstrated BM (basement membrane) 
disorganization 3 days after weaning (Strange et al., 1992). In addition, the activity of BM degrading 
matrix metalloproteinase (MMP) enzymes, which are important for gland remodelling at later stages of 
involution, is up-regulated 3–4 days after weaning. (Lund et al., 1996).  
There are two main ways in which the ECM can affect cell behaviour. One of these is through harbouring 
growth factors or growth factor-binding proteins. The other is that cell-ECM interactions can directly 
regulate cell behavior, either through receptor-mediated signalling or by modulating the cellular response 
to growth factors. For example ligation of integrins, the major class of ECM receptors, profoundly affects 
the cellular response to mitogenic signals, indicating that cell–matrix interactions are an important 
determinant in the regulation of cell cycle entry (MA Schwartz, 1999; A
signaling pathways specific to ECM integrin can alter interactions between steroid hormones and growth 
factors. For example, In vitro studies of the effects of ECM proteins in mammary epithelial monolayer 
cultures derived from adult mammary gland have been studied (Haslam SZ, 2001). Interactions between 
steroid hormones and growth factor and between two growth factors are influenced by ECM composition. 
Collagen type I (Col I) and fibronectin (FN) and, to a lesser extent, laminin (LM) promote an EGF+IGF-1 
synergistic effect on proliferation. No synergistic, additive or inhibitory effects of progestin or estrogen 
with growth factors are observed on Col I or FN. However, on LM, progestin reduces the proliferative 
response to growth factors (Woodward TL, 2000).  
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 2.3.3 Stromal-epithelial interactions during tumor formation 
As we all known, the essential functional component of the mammary gland is the mammary epithelial 
cell. This cell is the one that synthesizes milk proteins and can occasionally become neoplastic. Since we 
already talked about the profound roles of both stromal and ECM in regulating the normal behavior of 
mammary epithelium, it would not be unreasonable to propose that a breakdown in stromal structure 
nd/or cell interactions with extracellular matrix contributes to neoplasia. 
 place in the mammary gland stroma during 
isregulation of the proteinases 
a
It has been shown that certain physiological changes that take
involution are similar to those that occur during malignancy. These include enzyme degradation of the 
ECM, loss of cell adhesion, and breakdown of the basement membrane and release of growth factors. 
Unlike normal cells, malignant cells appear to be resistant to the apoptosis which occurs during tissue 
remodeling and thus these conditions may facilitate tumour cell dissemination and invasion. And the 
ability of tumor cells to cross tissue boundaries may be a result of m
relative to their inhibitors. Proteinases that degrade the extracellular matrix (ECM), including the serine 
proteinases and matrix metalloproteinases (MMPs) have been implicated in various pathological states 
such as inflammation, rheumatoid arthritis, and all stages of tumor progression including growth, invasion, 
metastasis, and angiogenesis. Werb and colleagues engineered the luminal mammary epithelium of mice 
to overexpress stromelysin-1 (One of the metalloproteinase), which predictably disrupted normal stromal-
epithelial interactions and perturbed tissue organization and differentiation. The experiments clearly 
showed that a desmoplastic stroma can drive malignant transformation of an epithelium (Werb.Z, 1996). 
Interestingly, in many carcinoma systems, most matrix metalloproteinases (MMPs) are largely expressed 
by the stromal cells, whereas the tumour cells are relatively silent in MMP expression. For example, to 
determine the tissue source of the most relevant MMPs, HBC cell lines and HBC tissues were 
xenografted into the mammary fat pad (MFP) or bone of immunocompromised mice and the expression 
of different MMPs were measured. The data directly demonstrate tumour induction of MMP production 
by stromal cells in both the MFP and bone environments and suggest that MMP-13 and MT1-MMP will 
be relevant targets for inhibiting breast cancer progression (Lafleur MA, 2004). To test the tissue 
organization field theory directly, recently, Maffini and co-workers used an acute chemical carcinogen 
(NMU) treatment to rapidly induce tumor formation, and a mammary gland epithelial reconstitution 
approach to distinguish between the contribution of stromal-epithelial interactions and genetic mutations 
to malignancy (Maffini et al., 2004). Interestingly, none of the animals that received MECs treated with 
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NMU in culture developed neoplastic lesions, unless their stromal fat pad had also received a prior bolus 
of NMU. It’s a further data to suggest that the stroma might itself constitute an important mutagenic target. 
 The paracrine factors have been widely implicated not only in the normal mammary parenchyma 
morphogenesis but also in the mammary carcinogenesis. Recently, mammary fibroblasts engineered to 
ectopically express HGF or TGFβ1 alone or together induced mammary epithelial to develop ductal 
carcinoma in situ, adenocacinoma, and poorly differentiated cancer, whereas transplantation of the same 
epitheial cell population with wild-type fibroblasts did not (Kuperwasser, C. et al , 2004). Using the 
conditional inactivation of the TGFβ type II receptor gene in fibroblast, Moses and colleagues have 
shown that TGF-β signaling in fibroblasts modulates the growth and oncogenesis of adjacent epithelia 
(Bhowmick NA).  
 
2.4 Mammary stem cells 
 
It is evident that the mammary gland possesses a strong regeneration capacity bypass the subsequent 
reproductive and lactation cycles. A logical question is then which cells offer this regeneration capacity 
and which cells will survive and which cells will be replaced during the dry period?  
he first question may be explained by the presence of a long-lived population of stem cells in mammary 
inite propensity to produce functional cells. Stem cells are undifferentiated, 
ivision-competent cells that reside in a given tissue, and that function to regenerate and/or replace all of 
 from CzechII MMTV-infected mice and transplanted them into 
leared mammary fat pads of syngeneic hosts. These hosts were mated and 1 day after parturition about 
oved for analysis, leaving the remainder intact for 
subsequent serial transplantation. As expected, most of the transplanted epithelial fragments expanded 
T
gland that have a near-inf
d
the cell types that compose that tissue. The presence of pluripotent stem cells and cell-line committed 
progenitors in the normal mammary gland has been described by several authors in different species such 
as the mouse, rat, human and cow. 
 
2.4.1.One cell, one mammary gland 
Kordon and Smith suggested the existence of a population of self-renewing and pluripotent stem cells in 
the mammary gland of mice. Using viral integration to mark and follow individual clones, they reported 
that a fully differentiated mammary gland could be derived from a single cell clone. They took small 
fragments of mammary epithelium
c
80% of each of the reconstituted glands was rem
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during pregnancy to become complete and functional mammary glands. If these glands had been derived 
from several different progenitors, no clear pattern of MMTV-insertional events would have been 
detected. If, on the other hand, the outgrowths were clonal a distinct and easily detected pattern of 
MMTV insertion sites would have been seen, as was the case in 20 of the 30 different outgrowths 
examined by Southern analysis. As a control, the intact contralateral glands of the host mice were 
analyzed in the same way and, as would be expected for a polyclonal tissue derived from several 
progenitors, no clear pattern of insertional events could be seen. The inescapable conclusion of this first 
part of the work of Kordon and Smith was that most of the reconstituted mammary glands were clonal. 
Fragments of these clonal glands were then transplanted into new hosts where they were shown to retain 
the same pattern of MMTV insertion sites, providing evidence of self-renewal of the original stem cell. 
Additional MMTV insertion sites were often detected, however, suggesting the acquisition of more 
mutations during clonal expansion. (Kordon & Smith 1998). 
2.4.2 Two lineage-specific progenitors come from one stem cell 
By transgenic mouse models, Kordon and Smith also demonstrated that regeneration of the mammary 
secretory lobules can be affected separately from the growth and development of the mammary epithelial 
ducts (Kordon & Smith 1995). This suggests that mammary epithelial stem cells capable of producing 
two functionally distinct progenitor cells in the mammary gland epithelium: one capable of producing 
daughters committed to ductal formation, the other capable only of producing daughters committed to 
panding and maintaining the number of mammary epithelial cells in subsequent 
lactation. 
lobular function.  
Two distinct epithelial cell progenitors have been identified by experiments designed to determine 
whether basal lobular and ductal phenotypes could develop independently under conditions imposed by a 
limiting dilution (Kordon & Smith, 1998). As these precursor cells are limited in their proliferation 
capacity, they need themselves to be renewed by cells originating from the pluripotent stem cell 
population. It can therefore be postulated that candidate cells for renewal are the precursor cells that are 
responsible for ex
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It was found that lobular i.e. secretory progenitor cells are present as distinct entities among the mammary 
epithelial cells of immature virgin female mice. Similarly, ductal epithelial progenitors are present within 
the same population, and both cell populations are extremely small (Kordon and Smith, 1995).  
Additionally, using cre-loxp system, Wagner et al. (2002) demonstrated that a newly matured epithelial 
sponse to 
lactogenic hormones. It was also presented the genetic evidence that despite the close morphological 
 
Mamm o g
basal and luminal cells. These intermediate cells ar
both light and electron microscopy (Chepko & S have few cellular organelles, pale 
light cells (SLC) and as an undifferentiated large light cells (ULLC). In 
rodents the results of in vitro and in vivo experiments suggest that the pale-staining or light cells situated 
cells during pregnancy permanently activates a ubiquitously 
expressed reporter transgene (Rosa-lacZ), whose expression is 
cell population which does not undergo cell death during involution or remodeling after lactation and 
function as alveolar progenitors. In this study, WAP-Cre transgene mice were crossed with reporter 
(Rosa-LacZ) mice to monitor the differentiation process of alveolar precursor cells in re
resemblance, an involuted mammary gland is fundamentally different from a virgin gland, due to the lack 
of the parity-induced population in the latter. 
 
 
Fig.10. The basic principle of the genetic labeling of 
differentiating cells in the developing mammary gland using the 
Cre-lox technique. In this experimental setting, the transient 
upregulation of Cre recombinase in differentiating epithelial 
 
 
 
 
 
2.4.3. Markers and morphology 
ary epithelial cells of a distinctive morph
nuclei and are found as a small 
y can be found in a position intermediate between the 
e distinguished by their pale-staining cytoplasm under 
mith 1997). They 
not dependent on the differentiation status of a given cell. The 
reporter gene remains active in cells that no longer require high 
systemic hormone levels to maintain a functionally 
differentiated state (i.e. WAP gene expression). Hence, the 
permanent activation of the reporter gene (blue X-Gal staining) 
genetically labels differentiating cells that bypass apoptosis and 
remodeling at the conclusion of the reproductive cycle. The 
labeled cells in the remodeled (involuted) gland represent a new 
epithelial subtype, which is not present in nulliparous animals 
(Wagner et al. 2002). 
lo
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between the luminal and the myo-epithelial cell layers are the most likely candidates for a stem-cell 
population (Chepko & Smith 1997). 
The isolation of stem cells from the mammary gland in human and rodents has been hindered by the lack 
of identified specific cell surface markers. In order to characterize putative epithelial stem cells further, a 
method successfully used for stem cell isolation in other tissues were used to isolate a side population 
(SP) from mouse mammary gland. The technique consists of staining isolated cells with Hoechst 33342 
followed by flow cytometric analysis to sort a ‘side population’ (SP) of cells that efflux the fluorescent 
void of 
oducing an entire new mammary epithelial 
tree. This approach relies on the remarkable organizational ability of both the mammary epithelium and 
pithelium and is not due to extracellular effects mediated within the 
transgenic environment and suggest that distinct progenitor populations exist for alveolar cells and for 
dye (Goodell et al. 1997). This shows that mouse mammary SP cells are enriched for expression of three 
putative stem-cell markers; Sca-1, α6-integrin and telomerase (Alvi et al. 2003; Welm et al. 2002). The 
percentage of mouse mammary SP cells was estimated to be 2–3% of all epithelial cells in one study 
(Welm et al. 2002) and 0.5% of total cells in the other (Alvi et al. 2003). Alvi et al. have further reported 
that nearly half of the SP cells were steroid receptor-positive and have produced preliminary data 
suggesting the presence of a similar SP population in human breast epithelium (Alvi et al. 2003). 
2.4.4. Experimental approach for mammary stem cell studies 
An in vivo transplantation system was used to evaluate the developmental capacities of specific mouse 
mammary epithelial cell populations. Mammary cleared fat pad and transplantation technique is to place a 
small piece of mammary tissue or mammary epithelial cells back into a fat pad that is de
endogenous epithelium, the injected material is capable of pr
stroma. It is an important method not only on normal mammary gland development, but also on the 
mammary stem cell exploration.  
One example of the power of the transplantation method using transgenic animals is the experiment of 
Smith who investigated the developmental potentials of mouse mammary epithelial cells in WAP-LacZ 
mice and TGFB1 mice (Kordon EC, et al 1995). By tranplantation, the results demonstrate the phenotype 
is a property of the transgenic e
ductal cells as well as for multipotent cells. Additionally, increased expression of TGFB1 preferentially 
affected alveolar-progenitor stem cells. Furthermore, The use of quantitative transplantation analysis 
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along with specific markers for stem cells would provide a more comprehensive understanding of the 
developmental capabilities of the mammary parenchyma at different stages as well as the effects of 
specific agents (i.e. TGFβ1, oncogenes) in these processes. The genetically engineered mice coupled with 
fluoresence-activated cell sorting analysis and transplantation into the cleared mammary fat pad is set as a 
model system to isolate and characterize functional mammary progenitors and stem cells 
In addition, the cleared fat pad allows serial transplantation of cell populations. Although established cell 
lines maintained in cell culture by serial passage have provided a useful means to study the effects of 
drugs and biological molecules on cell function and growth, this approach is often limited by the absence 
of tissue interactions. In contrast, the ability to serially transplant mammary cells into the mammary fat 
pad allows the establishment of stable and immortalized lines of non-neoplastic mammary cells analogous 
 
2.4.5. Cancer prevention and treatment 
Stem cells are important not only because 
replacment, but also because of the risk they
 indirect evidence that stem cells persist in
tic da
prime targets for oncogenic transformatio
to the established cell lines in vitro. 
 
is
them susceptible to accumulating gene
carcinogenesis is that cancer is a stem-cell
strategies must be targeted to mammary epi
    Cleared Fat Pad and Transplantationof the potential that they offer for organ regeneration or 
 pose in er is concerned, there 
 the mammary gland throughout life, this longevity makes 
mage during self-renewal, where they must be regarded as 
n. Thus, One implication of the ‘multihit theory’ of 
Fig.11.  Cleared Fat Pad technique 
carcinogenesis. As far as canc
 disease. If this is the case, then breast-cancer prevention 
thelial stem cells. Indeed, the presence of stem cells in the 
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mammary gland and susceptibility to carcinogens appear to be related. The greatest concentration of stem 
cells is in terminal end bud and alveolar bud structures during pubertal development in rodents, and it is 
during this period that the gland is most sensitive to carcinogens (Russo & Russo 1978a; Russo & Russo 
1978b). Similar structures exist in the breasts of prepubertal and adolescent women, and it is this age 
group that suffered the highest rates of breast cancer after irradiation due to the atomic detonations in 
Japan in 1945 (McGregor et al. 1977). 
In addition, little is known about whether tumours contain stem cells equivalent to normal tissues. Most 
current chemotherapeutic and endocrine agents induce apoptosis, but whether mammary stem cells are 
susceptible to programmed cell death is not known. Studies on the mouse small intestine suggest that 
there may be two populations of stem cells. One of these undergoes spontaneous apoptosis as part of the 
homeostatic mechanism restricting the number of stem cells present at any one time (Potten CS 1997). 
The other, smaller, population is resistant to radiation-induced apoptosis, undergoes DNA repair and, 
presumably, is responsible for repopulation of the damaged intestinal epithelium. If this is the case, then 
therapies aimed at killing proliferating cells may have little impact on this small number of tumour stem 
cells that remain quiescent, but which may cause tumour repopulation following treatment. Stem cells 
may also be responsible for local or distant recurrence that may occur several years after initial treatment 
of the primary tumour. It is therefore imperative that we identify tissue-specific stem cells and study their 
regulation in order to generate new targets for therapy that can prevent tumour stem cells from seeding 
tumour regrowth.  In mammary gland field, the model of transplanted mouse mammary gland refined by 
Kordon and Smith should allow us to determine whether mammary stem cells exhibit similar properties 
and to develop the means to overcome resistance to apoptosis. 
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 Part III  Integrins in the normal development and carcinogenesis of mouse mammary gland 
 
In part II, we mentioned that the mammary epithelium consists of two layers: a luminal layer of secretory 
cells and a basal layer of myoepithelial cells. Integrins exist in both of the layers. Immunohistochemical 
studies with human and mouse mammary gland tissue revealed the presence of α2, α3, α6, β1, and β4 
subunits in the luminal and myoepithelial cells and of α1, α5, and αv chains exclusively in the 
myoepithelial cells. The α5 and αv subunits seem to be expressed at lower levels than other integrin 
chains, being restricted to certain developmental stages and regions of the mammary tree. As expected, 
most integrins are present at sites of cell-ECM interaction, on the myoepithelial cells and on the basal 
surface of the alveolar luminal cells. The α2, α3, α6, and β1 integrin chains have also been found on the 
lateral surfaces of the luminal cells at sites of cell–cell interaction where ECM proteins are not detected in 
normal mammary epithelium. The activation status, potential ligands (if any), and functions of the 
integrins present on lateral cell surfaces are not known. These integrins may remain inactive or serve for 
homo- or heterotypic cell–cell interactions as it has been suggested to do in other cell types (Symington 
BE et al. 1993). 
 
 
 Fig.12. A schematic section through part of the 
mammary gland: the lactating alveolus) epithelial 
cells (blue) attach to the extracellular protein matrix 
(red) through a series of integrin proteins (green).  
 
 
 
 
 
 
Integrins have been identified as important regulators of mammary epithelial cell growth and 
differentiation. Their ability to promote cell anchorage, proliferation, survival, migration, and the 
induction of active ECM-degrading enzymes suggests that they play an essential role in normal mammary 
morphogenesis, but, on the other hand, reveals their potential to promote tumor progression. 
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3.1 Integrins play important roles in mammary gland development  
 
 Although data concerning the regulation of integrin expression during mammary gland development are 
rather fragmentary, there is enough experimental evidence to conclude that they are controlled 
transcriptionally and post-transcriptionally. Northern and western blotting performed with isolated rat 
mammary epithelial cells has shown that expression of the β1 and β4 chains increases during pregnancy. 
During lactation, β1 is further upregulated, and its expression level reaches a peak, whereas β4 level 
drops. (Huang R.Y. & Ip M.M, 2001).  
We observed similar changes of β1 integrin expression in the mouse stain C57Bl/6 (Fig.13). The 
upregulation of integrin β1 during late pregnancy and lactation suggests that integrins have important 
roles during these stages. 
 Fig.13. Expression pattern of β1-Integrin during murine mammary gland  development (BL/6) 
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3.1.1. Control of mammary epithelial cell proliferation and survival 
In normal adherent cells, activation of MAPKs and induction of proliferation in response to growth factor 
stimulation occurs only if cells interact with ECM. Moreover, integrin-mediated adhesion to ECM 
substrates is essential for cell survival (described more in Part I). Using a human breast cancer model, 
Weaver et al. could show that treatment of tumor cells in a 3-dimensional culture with inhibitory β1-
integrin antibody or its Fab fragments led to a striking morphological and functional reversion to a normal 
phenotype. The newly-formed reverted acini re-assembled a basement membrane and re-established E-
cadherin-catenin complexes, and re-organized their cytoskeleton. At the same time they downregulated 
cyclin D1, upregulated p21cip1 and stopped growing (Weaver T.M. et al. 1997). Moreover, reciprocal 
interactions between EGF receptor and integrin signaling pathways in the control of proliferation have 
been demonstrated by Wang et al. (Wang. F et al. 1998;Wang. F, et al. 2002). Inhibiting either EGF 
receptor or β1 integrin, in tumor cells growing in three-dimensional cultures in Matrigel, results in growth 
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arrest and restoration of normal morphogenesis. Similar results were obtained by inhibiting MAPKs or 
PI3K, the activation of which is triggered by integrins and growth factor receptors. Importantly, cell–
ECM interactions can regulate expression of the EGF receptor, as cells treated with function-blocking 
anti-β1 integrin antibody have decreased EGF receptor levels (Reginato M.j. et al. 2003).  
In the absence of a survival signal that is induced and maintained by integrins, normal, non-transformed 
mammary epithelial cells undergo apoptosis, termed in this case anoikis. Gilmore et al. showed that this 
process depends on the translocation of Bax, a proapoptotic protein of the Bcl2 family, from the cytosol 
to the mitochondria (Gilmore A.P et al. 2000). Adhesion signals mediated by focal adhesion kinase (FAK) 
prevent the activation of Bax and its translocation to the mitochondria. Bax is activated extremely rapidly 
after cell detachment (Wang.P et al. 2003), whereas subsequent events in the apoptosis program, such as 
cytochrome c release and caspase activation, occur after a considerable delay. Bim is another pro-
apoptotic protein induced in mammary epithelial cells following the loss of integrin-mediated adhesion to 
ECM (Reginato M.j. et al. 2003). Bim appears to be a powerful cell death inducer in mammary epithelial 
cells, as the downregulation of its expression by the RNAi technique inhibits anoikis. The engagement of 
β1 integrin, activation of the EGF receptor, and activation of the ERK MAPKs are required to block Bim 
expression in epithelial cells, clearly demonstrating that integrins trigger survival signals in concert with 
growth factor receptors. Stable overexpression of the EGF-receptor blocks cell detachment-induced Bim 
expression, leads to the activation of ERK in detached cells, and prevents apoptosis. Thus, overexpression 
of the EGF-receptor may enable cells to escape anoikis; lead to a loss of anchorage dependence (Reginato 
M.j. et al. 2003) and this could be involved in the cancer development. 
Phosphatidyl-inositol-3-kinase (PI3K) and the serine/threonine kinase Akt are required for transmission 
of the cell survival signal triggered by integrin mediated adhesion. PI3K is a downstream effector of 
insulin receptor signaling and is activated upon treatment of cells with insulin or insulin-like growth 
factors. After several days of primary culture, mammary epithelial cells grown on collagen I undergo 
apoptosis, whereas those cultured on Matrigel in the presence of insulin or insulin-like growth factors (but 
not prolactin or hydrocortisone) do not (Farrelly.N et.al. 1999). The α6 and β1 integrin subunits have 
been found to be required for mammary epithelial cell survival under these conditions. The 
phosphorylation of insulin receptor substrate-1, its binding to PI3K, and the phosphorylation of Akt are 
all enhanced in cultures on Matrigel, suggesting that cell–ECM interactions and PI3K pathway signaling 
via the insulin receptor control survival/apoptosis in mammary epithelial cells (Farrelly.N et.al. 1999; Lee 
Y.J and C. H. Streuli, 1999). 
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The first evidence that β1 integrins are involved in the control of cell survival and proliferation during 
mammary gland development in vivo came from transgenic mice expressing a chimeric molecule 
consisting of the cytoplasmic and transmembrane domains of β1 integrin fused to the extracellular 
domain of CD4 (MMTV-β1-cyto) in mammary epithelial cells. This chimeric molecule does not bind 
ECM ligands and in cultured cells, acts as a dominant negative mutant of β1 integrin. The mammary 
glands of MMTV-β1-cyto females displayed low epithelial cell proliferation and high apoptosis rates 
during the intensive growth phase of mid-pregnancy and early lactation, accompanied by a lack of 
activation of the MAPKs, ERK, and JNK (Faraldo MM et al. 1998&2001). PI3K activation upon 
adhesion leads to the phosphorylation of Akt, which in turn phosphorylates the pro-apoptotic protein Bad. 
These phosphorylation events are essential for cell survival. In the mammary glands of MMTV-β1-cyto 
mice, Akt and Bad were all found to be less phosphorylated than in wild-type animals, revealing a 
deficiency in activation of the PI3K pathway accompanying the perturbation of β1 integrin function 
(Faraldo MM et al. 2001). Important evidence supporting the involvement of β1 integrins in the control of 
mammary epithelial cell survival in vivo was obtained by Prince et al. (Prince et al. 2002). This study 
demonstrated that although β1 integrin was present in mammary epithelial cells at all developmental 
stages, the amount of ligand-associated β1 integrin detected with a conformation-sensitive antibody 
decreased markedly at the onset of involution prior to the peak of apoptosis. Finally, an interesting 
finding suggesting that integrins may transmit pro-apoptotic signals was reported by Seewaldt et al. 
(Seewaldt VL et al. 2001). Human mammary epithelial cells expressing p53 undergo growth arrest and 
form acinus-like structures after several days of culture in Matrigel, whereas cells with suppressed p53 
function, under the same experimental conditions, undergo apoptosis. Cell death can be prevented by 
incubation with anti-β1 or anti-β3 function blocking antibodies, suggesting that α3β1 integrin may be 
involved in the induction of apoptosis in the cells lacking active p53 (Bachelder RE et al. 1999). 
 
3.1.2.Control of mammary epithelial cell differentiation 
Pioneering studies indicated that the cellular microenvironment is critical for mammary epithelial 
differentiation. For example, primary mammary epithelial cells can maintain the glucose metabolic 
patterns of lactating gland and secret milk proteins in response to the lactogenic hormones when the cells 
are cultured on a collagen I gel which is floated into the medium. However, these cells lose their 
differentiation when they were cultured in conventional tissue culture conditions, even in the presence of 
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the lactogenic hormones (Lee, E.Y.H  et al. 1984). These experiments provided some of the first evidence 
that tissue microenvironment and cell shape are prerequisites for tissue specific gene expression. 
Interestingly, the induction of differentiation in cells cultured on floating collagen gels correlated with 
deposition of an endogenously synthesized basement membrane. Direct evidence of a role for basement 
membrane in differentiation came from the observation that single, isolated mammary cells could be 
induced to express β-casein in the presence of basement membrane proteins but not on the collagen I 
(streuli C.H et al. 1991). 
Integrins are major receptors for extracellular matrix proteins, including basement membrane 
components. Studies with functional blocking integrin antibodies have been used to demonstrate their 
requirement for the mammary epithelial differentiation. Anti-β1 integrin antibody inhibited the ability of 
mammary cells embedded within basement membrane to express the milk protein β-casein, wherera other 
blocking antibodies such as one for E-cadherin did not block the differentiation (Streuli C.H et al. 1991). 
Thus, integrins act as basement membrane receptors to trigger a signalling pathway leading to milk 
protein expression.   
Basement membrane signals could regulate mammary differentiation at the transcription level. A 
transcription factor, STAT5 (signal transducer and activator of transcription 5), has been shown to play a 
critical role in mammary gland development and in the control of milk gene expression (More details in 
Part II).  Experiments carried out with mammary epithelial cells in culture have shown that the activation 
of STAT5 via the prolactin receptor pathway requires β1 integrin-mediated interaction with laminin, the 
major component of Matrigel. Prolactin does not induce phosphorylation of its receptor, JAK2 or STAT5, 
if mammary epithelial cells are cultured on interstitial collagen I (Streuli C.H et al. 1995). Moreover, both 
β1 and β4 integrin signals are required for β-casein gene expression by mammary cells cultured on 
Matrigel, suggesting that these integrins act in concert in the control of mammary epithelial cell 
differentiation (Muschler J, et al. 1999). 
The perturbation of β1 integrin function in vivo (MMTV-β1-cyto mouse model) results in the impaired 
differentiation of secretory epithelial cells at the beginning of lactation and precocious dedifferentiation 
during involution, as estimated by levels of β-casein and WAP gene transcripts (Faraldo MM et al 1998). 
The precocious dedifferentiation of the secretory epithelial cells in these transgenic mice is caused by a 
lack of activated STAT5 in the nuclei. However, STAT5 and JAK2 phosphorylation levels are unaffected 
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in the mammary glands of these transgenic mice. These findings suggest that β1-integrin signaling may 
have an impact on STAT5 activity, not only by controlling STAT5 phosphorylation, but also by affecting 
the translocation of STAT5 into the nucleus. The perturbation of β1 integrin function during involution 
also leads to the precocious activation of NF-KB, which can compete with STAT5 for transcriptional 
coactivators and may therefore inhibit the STAT5-dependent transcription of milk protein genes (Faraldo 
MM et al 2002). 
Overall, these studies convincingly demonstrate that basement membrane is essential for the development 
and differentiation of mammary epithelium. The integrin receptors, including β1 integrins and α6β4, are 
involved in the control of mammary epithelial cell terminal differentiation. 
 
3.2 Integrins and breast carcinogenesis 
 
3.2.1. Integrin expression and function in breast carcinogenesis 
In normal breast, intense staining of many integrin subunits is seen concentrated at the basement 
membrane in the myoepithelial layer. In invasive carcinomas, this cell layer is most often absent and the 
expression of integrin subunits on the surface of carcinoma cells is diffuse. This led to the erroneous 
assumption that there is an overall decrease, or absence, of integrin expression in breast carcinoma. 
Although the expression of some integrin subunits is decreased, it is clear from many in vitro and in vivo 
studies that integrin receptors are expressed in breast adenocarcinomas and that they contribute 
significantly to the pathobiology of breast cancer.  
Integrins have been implicated in several aspects of tumor progression, including tumor cell survival, 
induction and activation of matrix-degrading enzymes, migration, and anchorage at the sites of 
metastasis. In this respect, α6β1 and α6 β4, which act as laminin receptors, are the best-studied integrins. 
They promote the survival and migration of breast carcinoma cells. α6 expression is strongest in the 
myoepithelial cells and the staining is predominant at the basal surface in contact with the basement 
membrane. High levels of α6 integrin chains in human mammary carcinoma are clearly correlated with 
low patient survival rates (Friedrichs K et al. 1995). In vitro, in highly metastatic human mammary 
carcinoma cell lines, the inhibition of α6β1 integrin dimer formation abolishes tumor growth and 
metastasis. High levels of apoptosis are observed in the tumors formed by cells lacking the α6 β1 dimer. 
These observations provide evidence that the α6 β1 integrin promotes cell survival in mammary tumors 
(Wewer UM et al. 1997). The α6 β4 integrin, in addition to promoting tumor cell survival, also increases 
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the motility of tumor cells. Carcinoma cell lines often express high levels of α6 β4 integrin but do not 
form hemidesmosomes, which anchor the cells and hinder migration. In this case, α6 β4 is associated 
with actin microfilaments in the invasive membrane protrusions and serves to enhance motility. The α6β4 
integrin is also involved in the activation of PI3K, the small GTP-ases Rho and Rac, and protein kinase 
A, which are all essential for carcinoma migration and invasion (Mercurio AM et al. 2001; O’Connor & 
Mercurio, 2001). α6β4 mediated compression enables carcinoma cells to remodel the basement 
membrane by a process involving the packing of basement membrane material under the cells and the 
mechanical removal of this material from adjacent areas (Rabinovitz I et al. 2001). 
In the mammary tumorigenesis studies, α2β1 is a special in comparison with the other integrins we 
discussed above. The α2β1 integrin is a dual-specificity receptor that recognizes collagens I and IV and 
members of the laminin family. The α2 subunit is expressed basally as well as laterally in luminal 
epithelial cells. The expression of α2β1 is maintained in benign breast lesions such as fibrocystic disease 
or fibroadenomas (Zutter MM et al. 1990). However, the expression level of α2β1 decreases with the 
differentiation status of breast adenocarcinomas. Specifically, poorly differentiated adenocarcinomas 
express very low, or undetectable levels of α2β1 while moderately differentiated adenocarcinomas 
express intermediate levels (Zutter MM et al. 1990&1993). These correlative studies suggested that the 
α2β1 integrin is important for maintaining the differentiation and controlling proliferation of the breast 
epithelium and that its loss is essential for the progression to invasive carcinoma. 
 
3.2.2 Integrin linked kinases 
Two important enzymes that associate with focal adhesions are focal adhesion kinase (FAK) and integrin-
linked kinase (ILK). Because of their ability to bind many adaptor proteins and other signaling enzymes, 
FAK and ILK are viewed as critical components that integrate cell–ECM interactions with cell 
phenotype. Besides these, they were found to be involved in the progression of breast tumor.  
FAK is over-expressed in a number of human tumors, such as colon and breast carcinomas, sarcomas, 
ovarian carcinomas etc. A correlation between the expression level of FAK and the invasive potential of 
the cancer has been described in most of these studies. Possible mechanisms that lead to elevated FAK 
expression might involve increased dosage and amplification of the FAK gene, as observed in cell lines 
derived from human tumors of lung, breast and colon, or its constitutive activation, as described in 
malignant melanoma cells (Kahana O et al. 2002). Cancer studies show that FAK might play a role in 
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suppressing apoptosis. For example, down regulation of FAK with antisense oligonucleotides results in 
apoptosis of tumor cells in culture, as does the inhibition of its function by expression of either FRNK or 
the N-terminal domain (Beviglia L et al. 2003). Furthermore, breast tumor cell lines that are viable 
without ECM attachment also undergo apoptosis upon interruption of FAK function, demonstrating that 
FAK is a survival signal even in the absence of matrix signaling (Xu LH et al. 2000). 
An important function of ILK is structural and, together with its associated proteins, this kinase serves to 
provide an essential component linking the cytoskeleton with integrin attachment sites. At the time of its 
original identification, ILK was proposed to be involved with neoplastic progression because ectopic 
expression of human ILK disrupted cell adhesion to ECM and induced transformation of intestinal 
epithelial cells, as judged by anchorage independent growth (Hannigan GE et al. 1996).  
 
ILK may also be involved with neoplastic progression in the mammary gland, although no studies have 
yet been carried out to examine whether its expression or activity is altered in human breast cancer. In a 
transgenic mouse model, human ILK expressed under the control of the MMTV promoter induced 
epithelial hyperplasia within 6 months, and focal mammary tumors (with a range of different 
morphological phenotypes) appeared in 34% of animals at an average age of 18 months (White DE et al. 
2001). The proliferative response in the epithelium of transgenic glands was accompanied by constitutive 
phosphorylation of PKB, GSK3β, and MAPK. Although it is not clear whether this phosphorylation is 
directly responsible for increased proliferation, other studies in MCF7 cells have indicated that ILK can 
increase the activity of the cyclin D1 promoter (D’Amico M et al. 2000). 
 
3.2.3. Integrin cooperativity with growth factors  
An emerging area in the study of integrin contributions to cancer is the cross-talk between these adhesion 
receptors and soluble growth factor and cytokine receptors. As mentioned in part II, in the normal breast 
integrin receptors cooperate with hormones and growth factors to promote mammary epithelial 
differentiation and function. An increasing number of studies indicate that integrins also cooperate with 
soluble factors to promote carcinoma progression. 
Integrins can cooperate with growth factor receptors to enhance their signaling capabilities. For example, 
α6β1 and α6β4 integrins can associate with the ErbB2 protein and increase its signaling functions. The 
NIH3T3 cells, which have over expressed both α6β4 integrin and erbB2 receptors, but not those 
overexpressing a crippled ErbB-2, showed enhanced proliferation rates and invasiveness (Falcioni R. et 
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al. 1997).  Another mechanism of integrin-growth factor receptor cooperation involves integrin activation 
by growth factors and cytokines. A well-studied example is the activation of the αvβ5 integrin by the 
insulin-like growth factor receptor (Brooks PC et al, 1997). Breast carcinoma cells that express 
αvβ5 adhere to but do not migrate on vitronectin in vitro unless they are stimulated with IGF-1 or insulin. 
In vivo, these cells form tumors in the absence of IGF-1, however, they only metastasize when stimulated 
with IGF-1 or insulin (Brooks PC et al, 1997). These data suggest that the cooperation between αvβ5 and 
the IGF-1 receptor may regulate migration and invasion to promote the metastatic spread of tumor cells. 
 
3.2.4. In vitro and in vivo models 
Since many integrins have the potential to promote tumor progression, antagonists of integrins, such as 
blocking antibodies or peptides, have been used to inhibitor the function of integrins in tumor cells. For 
example, vascular integrins, in particular αvβ3, are important regulators of angiogenesis, including tumor 
angiogenesis. It has been shown that integrin αvβ3 antagonists could suppress tumor angiogenesis and 
tumor progression in many preclinical tumor models. In some breast cancer cell lines, functional integrin 
β1 specific antibodies with the capacity to override the oncogenic events and yield tumor revertant cells 
have been found. For example, in a developed human breast cancer model (HMT-3522 human breast 
cancer cell line), treatment of tumor cells in a 3-dimensional culture with inhibitory β1-integrin antibody 
or its Fab fragments led to a striking morphological and functional reversion to a normal phenotype 
(Weaver V.M. et al. 1997). The newly formed reverted acini re-assembled a basement membrane and re-
established E-cadherin-catenin complexes, and re-organized their cytoskeletons. At the same time they 
downregulated Cyclin D1, upregulated p21cip1, and stopped growing. Tumor cells treated with the same 
antibody and injected into nude mice had significantly reduced number and size of tumors in nude mice. 
The tissue distribution of other integrins was also normalized, suggesting the existence of intimate 
interactions between the different integrin pathways as well as adherens junctions. On the other hand, 
nonmalignant cells when treated with either α6 or β4 function altering antibodies continued to grow, and 
had disorganized colony morphologies resembling the untreated tumor colonies. This shows a significant 
role of the α6/β4 heterodimer in directing polarity and tissue structure. The observed phenotypes were 
reversible when the cells were disassociated and the antibodies removed (Weaver V.M. et al. 1997).  
A recent paper by White et al. shows that β1 integrin is required for mammary tumor growth in vivo. 
Using cre-loxp recombination system to disrupt β1-integrin function in a transgenic mouse model of 
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breast cancer, they could show that β1-integrin expression is critical for the initiation of mammary 
tumorigenesis (White, DE et al, 2004). Although ablation of β1 integrin expression from cells of the 
mouse mammary epithelium did not impair mammary gland development during puberty, deletion of the 
conditional β1-integrin allele dramatically impaired mammary tumorigenesis in the MMTV/PyV MT 
(polyomavirus middle T oncogene) mice. In addition, the deletion of β1 integrin in cultured mammary 
tumor cells was found to be associated with a decrease in the phosphorylation of FAK tyrosine residues, 
including the c-Src binding site. The deletion of β1 integrin from these PyV MT-induced tumor cells also 
inhibited the capacity of these cells to proliferate and form tumors in vivo. Taken together, all these 
observations suggest that β1 integrin plays a critical role in both the initiation and maintenance of 
mammary tumor growth in vivo (White, DE et al, 2004). 
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 Part IV: Summary and open questions 
 
To summarize, integrins play essential roles in the development of the mammary gland. The integrin β1, 
one of the main integrin subunit in the mammary gland, plays important roles in mammary epithelium 
proliferation, differentiation, and apoptosis. Besides their functions in the normal mammary gland 
development, they also have potentials to promote mammary tumor progression. 
Although different approaches to interfering β1 integrin expression have been applied to investigate the 
role of integrin β1 in the mammary gland development and mammary tumorigenesis, some limitations of 
these approaches have left many questions open for clarification. For example, what is the role of integrin 
β1 in the specific mammary cell type, or the specific time and window in the mammary gland 
development? What is the molecular mechanism which blocks tumor cell proliferation after β1 integrin 
deletion? 
As mentioned, Faraldo used a dominant negative transgene (CD4-β1 integrin) to interfere with β1 
integrin function in the gland (Faraldo MM et al. 1998). However, dominant negative approaches have 
some limitations. Furthermore, integrins are unique molecules that transduce signals in two directions. 
Thus, the portion of β1 integrin remaining in the dominant negative transgene namely the transmembrane 
and intracellular domain still has the potential to transmit signals. In addition, it is known that depending 
on expression level, CD4-β1 integrin can act either in a dominant negative or a dominant active manner. 
Thus, to understand the role of integrin β1 more precisely in the mammary gland development and clarify 
the molecular mechanism, a genetic approach is very appropriate. 
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Aims of the Ph.D. Project 
(1) To determine the role of β1 integrin in normal development of the mouse 
mammary gland, with a particular emphasis on how β1 integrins influcence 
proliferation, differentiation and apoptosis.  
By using conditional deletion strategy, this was explored in a specific time and 
window in vivo. 
 
(2) To investigate the molecular mechanisms for the phenotypes we observed in 
vivo.  
The uncovering of such mechanisms will explain how β1 integrin affect normal 
development; this could provide clues for the breast cancer investigation. 
 
(3) Based upon results obtained in vivo, to establish an in vitro system that mimics 
the effects of deletion of the integrin β1 in the mouse. 
The aim is to gain experimental flexibility by using an in vitro model that can be 
more easily manipulated than the current mouse model and allow us to further 
investigate the molecular mechanisms underlying the in vivo phenotypes. 
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Results: 
 
 
Conditional deletion of β1 integrin in the mammary gland 
To inactivate the Itgβ1 gene in the mammary gland, we crossed Itgβ1flox/flox mice (Graus-Porta et al., 2001) 
with WAPiCre transgenic mice (Wintermantel et al., 2002). WAPiCre is specifically expressed in the 
luminal epithelial cells of the gland starting at midpregnancy and reaches a maximum at day 3 of lactation 
(Wintermantel et al., 2002)(Fig 2A panel d). WAPiCre is not expressed in the ductal tree of the virgin 
gland, nor is it expressed in the basal myoepithelial cells of the mammary gland (Wintermantel et al., 
2002)(N. Li, unpublished observations and Fig 2A panels b & d). Littermates with the genotype 
Itgβ1flox/flox; WAPiCre-/- (referred to as control mice) or Itgβ1flox/flox; WAPiCre+/- (referred to as β1-integrin 
mutant mice) were used for all analyses.  
Mammary glands from 3-day lactating females were used to examine Cre-mediated recombination. A 
PCR analysis carried out on DNA from mammary tissue, revealed the expected 1.3 kB product resulting 
from the recombined Itgβ1 allele in mutant mice (Fig 1B). The unrecombined 2.1 kB floxed allele was 
detected in control mice and in mutant mice due to the presence of myoepithelial and stroma-derived cells 
(Fig 1B). Western analyses for β1 integrin protein revealed a strong decrease in expression in the 
recombined mutant glands, compared to control glands (Fig 1C), corroborating the PCR results. β1 
integrin is not totally absent since expression remains in the myoepithelial cell layer. 
Immunohistochemical analyses carried out on glands from control 3-day lactating females revealed the 
expected localization of β1 integrin to the basal layer of the myoepithelial cells, and to the basal-lateral 
layer of the luminal cells (Fig.2B, panels e & g; white arrow indicates lateral staining) (Prince et al., 2002; 
Taddei et al., 2003). In lactating glands from β1 integrin mutant females, the majority of luminal cells 
were negative for β1 integrin immunostaining (Fig. 2B, panels f & h), which was most obvious on the 
lateral surface of mutant cells (white arrow, panel g vs. yellow arrow, panel h). The remaining β1 integrin 
immunostaining is from the myoepithelial cells. These results demonstrate the development-specific 
ablation of β1 integrin in the luminal cells of the mammary alveoli. 
To examine directly the functional consequences of β1 integrin ablation on cell adhesion, we performed 
adhesion assays using primary mammary epithelial cells prepared from 5-day lactating glands. There 
were no striking differences in the adhesion of control and β1 integrin mutant cells plated on poly-D-
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lysine (PDL), collagen I (Cl), fibronectin (FN), and gelatin (Fig 1F). However, primary cells from β1 
integrin-mutant glands displayed a severely reduced adhesion on laminin, the major β1 integrin ligand in 
the mammary gland (Prince et al., 2002) (Fig 3, LN).  
 
Function of mammary gland was impaired in β1 integrin mutant mice 
The body weight of litters nursed by either control or integrin β1 mutant mothers were monitored from 
new birth until lactation day 20 (Fig. 4A). The pup weight of pups nursed by mutant mothers began to 
decrease after first round lactation day 5. These pups appear visibly malnourished after first round 
lactation day 14. (Fig. 4A) 
Interestingly, at the secondary lactation stage, the pups nursed by mutant mothers appear visible 
malnourished after lactation day 1, and pup weight of pups nursed by mutant dams reduced dramatically 
in comparison with first round lactation stage (Fig.4B). 
To check the secretion and the quantity of the milk, at first round lactation-day-5 and lactation-day-14, 
control and mutant mice were injected with oxytoxin and milk were collected from #4 mammary glands 
of each mouse. Preliminary data showed that consistent with the functional pup weight analysis, control 
or mutant dams secret similarly volume of milk at lactation-day-5, but there is only little milk secretion 
by mutant mothers at lactation-day-14 (Fig.5C) 
Electrophoretic separation of control or mutant milk samples showed similar milk expression patterns at 
lactation day 5 or lactation day 14, including milk proteins WAP and β-casein (Fig 5A). Western blot 
analysis also showed similar β-casein expression pattern at different lactation stages (Data not shown).  
The prolactin receptor and its effectors, janus kinase 2 (Jak2) and signal transducer and activator of 
transcription 5 (Stat5) have essential roles in mammary gland development and functional differentiation 
(Liu, 1997; Brisken, 1999; Shillingford, 2002). The activity of Stat5 and Jak2 in control and β1 integrin 
mutant mammary glands was examined using phospho-Tyr specific antiserum. P-Stat5 levels were 
strongly- and P-Jak levels slightly-decreased in 3-day lactating glands of mutant females. By 14 days the 
activity of both proteins was near normal (Fig.5B).  
  ERBB families of type 1-receptor tyrosine kinases and their ligands have crucial functions during 
mammopoiesis. Recently, ErbB4 was found to be an essential mediator of STAT5 signaling (Long et 
al.2003). In wild type or mutant mouse mammary glands, erbB4 protein was localized within luminal 
epithelial nuclears at early lactation (fig 5D, upper panel). It was trans-localized to membrane at late 
lactation both in wild type or mutant glands (Fig 5D, lower panel). But the mutant gland sections had 
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more diffused staining.  The integrity of erbB4 staining was not as good as the staining in wild type 
sections (Fig 5D, low panel, Right).  
We already showed that expression of the milk proteins β-casein and WAP was normal in mutant mice, 
suggesting that the decrease in Jak2/Stat5 activity early in lactation did not have an overall effect on milk 
protein production. As discussed above, the phosphate cotransporter isoform Npt2b staining (Fig8, panel 
c&d), a marker of functional alveolar differentiation (Shillingford, 2003), which is expressed on the 
apical surface of secretory cells (Miyoshi et al., 2001),  was normal in β1 integrin null cells. (Fig 8, panel 
d). Taken together, these results suggest that functional differentiation of mammary glands lacking β1 
integrin is normal, and the decreased pup weight nursed by mutant mice might be due to the impaired 
milk secretion of the mutant mammary glands. 
 
β1 integrin-mutant mammary glands have defects in alveolar integrity due to detachment of 
luminal epithelial cells  
The morphology of control and β1-integrin mutant mammary glands was assessed by whole-mount 
analysis and hematoxylin and eosin (H & E) staining of paraffin sections. Whole-mounts showed that 
during pregnancy and lactation the overall organization of the ductal trees and alveoli were normal in the 
absence of β1 integrin (Fig.6, panel a-d). H & E stained paraffin sections also showed no significant 
differences in either the development of the lobular-alveolar structures or their density in control 
compared to β1-integrin mutant glands taken from 16.5- day pregnant or 1-day lactating mice (Fig 7A, 
panels a & c vs. b & d, respectively and at higher magnification panels g & i vs. h & j, respectively). 
However, at lactation day 5 there was a noticeable change in the alveolar integrity of the glands from β1 
integrin mutant females. Luminally shed cells or bulging cells in the process of shedding were detected 
(Fig 7A, panel f, yellow & black arrows, respectively). In control females, there are very few detached 
cells and quantitation revealed an 11-fold increase in shed and bulging cells after loss of β1 integrin. (Fig 
7A, panel e & f, white box). This phenotype was maintained at later stages of lactation (Data not shown). 
Interestingly, at secondary late-pregnancy and early lactation, the alveolar density severely reduced in 
comparison with control mammary glands either by whole mount analysis (Fig.6 e-h) or by H&E staining 
(Fig.7B:a-d). An examination of lactating mammary glands from females after a second lactation 
revealed the same phenotype, i.e., the integrity of the gland was disturbed and many cells were shed into 
the lumen of β1 integrin mutant females (Fig 7B, panels b & d, higher magnification). The density of the 
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lobular-alveolar structures was also decreased in the β1 integrin mutant females compared to controls at 
day 5 of the first lactation (Fig. 7B, panel d vs. c). These results suggest that loss of β1 integrin decreases 
luminal cell-matrix adhesion, resulting in loss of alveolar integrity. Moreover, the decreased alveolar 
density suggests that proliferation of mammary cells in the absence of β1 integrin might be affected.  
Next, we examined mammary glands from 5-day lactating females with various markers to probe the 
integrity of the alveolar structures. Staining for the myoepithelial marker smooth muscle actin did not 
reveal any differences between β1 integrin mutant and control glands (Fig.8, panels a & b). Staining with 
a laminin-1 antiserum showed that BM localization was normal in the control and mutant glands (Fig.8, 
panel e & f), however, it is evident that in these glands many luminal cells have lost their ability to adhere 
to the BM and have been shed, or are in the process thereof (Fig 8, panel f, white arrows). E-cadherin 
showed a basal-lateral localization in control luminal cells. This pattern was altered in some luminal cells 
of β1-integrin mutant glands (Fig 8, panel g & h), which correlates with decreased E-cadherin levels in 
the mutant glands (Fig. 11D). The expression of β-catenin was normal in mutant glands at early latation 
while it was decreased at lactation day 14(Fig. 11D). We also observed a decrease in the tight junction 
protein ZO-1 late in lactation, which might result from decreased E-cadherin levels since assembly of 
tight junctions depends upon E-cadherin recruitment to adherens junctions (Data not shown). Thus, with 
respect to a myoepithelial cell marker, BM deposition and an apical epithelial marker, mammary glands 
from mice lacking luminal β1 integrin appeared normal. The major phenotype of β1 integrin mutant 
glands was a decreased association of the luminal cells with the laminin-1 rich BM, leading to loss of 
epithelial integrity and increased shedding of cells into the lumen of the gland.  
It is noteworthy, however, that β4 integrin, which is localized to the basal surface of the luminal and 
myoepithelial cells in control glands (Fig.8, panel i), was relocalized in β1 integrin mutant glands; in 
additional to basal staining, β4 integrin was also detected on the apical surface of some luminal cells 
(Fig.8, panel j). Phalloidin was used to visualize actin, since β1 integrins connect the ECM to the actin 
cytoskeleton. Actin stress fibers running along the basal surface of the cells were evident in sections from 
control glands (Fig.8, panel k). In contrast, there were no stress fibers evident in β1-integrin mutant 
glands. Furthermore, strong actin staining was also evident in some lateral and apical surfaces (Fig.8, 
panel l), suggesting that in the absence of luminal β1 integrins, the actin cytoskeleton has become 
disorganized. 
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β1 integrin mutant mammary glands show a slight increase in apoptosis at involution, but not 
during lactation  
Various lines of evidence point to the important role of integrin-mediated adhesion in mammary cell 
survival. Primary mammary cells undergo apoptosis unless cultured on laminin, or when β1 integrin 
function is perturbed (Pullan, 1996b; Gilmore, 2000). Accordingly, we examined mammary glands from 
β1 integrin mutant mice for apoptosis using the TUNEL (terminal deoxynucleotidyl transferase mediated 
dUTP nick end labeling) assay. Apoptotic cells were not detected in lactating glands from β1 integrin 
mutant mice and luminally shed cells were not TUNEL positive (data not shown). Electron microscopy 
(EM) was also used to investigate cells at a higher resolution. Neither cells that lost contact with their 
neighbors (Fig 9A, N), nor cells that had detached and were in the lumen (Fig 9B, white circled cell), 
showed evidence of apoptosis. In particular, the nuclei of these cells appeared normal and did not show 
apoptotic characteristics, such as condensed nuclear fragments (the casein micelles and milk-fat droplets 
are evident in the milk of β1 integrin mutant females). 
Considering that apoptosis is generally low during lactation, we also examined involution, a 
developmental stage with high levels of cell death (Strange et al., 1992; Green et al., 2004). Litters were 
removed from 9-day lactating control and β1 integrin mutant females to induce involution; 24 hrs later 
mammary glands were isolated and examined (Prince et al., 2002). H & E stained paraffin sections 
revealed that involuting glands from β1-integrin mutant mice had 4-5 fold more shed cells in the lumen in 
comparison to controls (Fig. 10, top panels and quantitation on the right). TUNEL staining was also 
performed on the sections. Quantitation of positive cells, both alveolar and shed, revealed a 1.5-fold 
increase in apoptotic cells in β1-integrin mutant mammary glands, compared with control glands (Fig. 10, 
lower panels and quantitation on the right), however, this increase is not significant. It is noteworthy that 
not all shed cells were TUNEL positive (black vs. green arrows in panel d).  
STAT3 is pro-apoptotic and is a crucial mediator of post-lactational regression (Chapman et al., 1999). 
Using conditional gene targeting, it has been shown that in the absence of STAT3, involution is delayed 
for several days, owing to a reduction in apoptosis, and this is associated with elevated levels of p53 
(TRP53 -; Mouse Genome Informatics) and p21, precocious activation of STAT1, and failure to induce 
IGFBP5. After loss of integrin β1, at lactation day 3 and day 14, the phosphorylation of stat3 was 
decreased (Fig.11, panel A). We also checked the expression of p53 and another pro-apoptotic marker 
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Bax. In the absence of integrin β1, the expression of Bax was increased throughout lactation, while the 
express of p53 was only upregulated during late lactation (Fig.11, panel B). 
The serine/threonine kinase PKB transmits survival signals triggered by integrin-mediated adhesion 
(Datta et al., 1999). The activity of this kinase was assessed using an antiserum specific for the active, 
phosphorylated form.  There was no difference in the level of Ser 473 phosphorylated PKB in extracts 
from lactating glands of β1-integrin mutant mice compared to control mice. Furthermore, 
phosphorylation of Ser 9 of glycogen synthase kinase 3-β (GSK3β), a downstream target of PKB, was not 
altered in β1-integrin mutant mammary glands (Fig.11, panel B). 
Taken together, the results suggest that in the absence of β1-integrin, the epithelial cells are shed more 
easily into the lumen of the gland. This phenomenon is apparently not due to increased apoptosis during 
lactation, but very likely due to decreased adherence of the luminal cells to the BM in the absence of β1 
integrins, suggesting that loss of integrin β1 couldn’t trigger the apoptosis in mammary luminal epithelial 
cells during lactation.  At involution, there is a slight increase in the number of apoptotic cells, but this 
increase is not significant. 
 
Loss of β1 integrin correlates with reduced mammary cell proliferation and upregulation of p21Cip1  
At the start of lactation the mammary gland undergoes a proliferative burst. To examine whether β1 
integrin is involved in this process, 2-day lactating females were injected with bromodeoxyuridine (BrdU) 
2 hrs before sacrifice and paraffin sections from the isolated mammary glands were examined with anti-
BrdU monocloncal antibody. In control mice approximately 8% of the luminal nuclei stained positively, 
while only 2% of the luminal cells in mammary glands from β1 integrin mutant mice showed BrdU 
incorporation (Fig. 12A, panels a & b; quantitation in c). Thus, mutant glands show a strong reduction in 
proliferation at the start of lactation.  
Progression through the cell cycle is regulated by periodic activation and inactivation of cyclin dependent 
kinases (CDK). To provide a mechanistic understanding of the decreased proliferation rate in the β1 
integrin mutant glands, we examined the level of positive and negative CDK regulators, the cyclins and 
the CDK inhibitors (CKI), respectively. Cyclin D1, an important G1 regulator in the mammary gland 
(Sicinski et al., 1995) was slightly increased in lactating glands from mutant mice; while neither cyclin E, 
cyclin B1 nor CDK2 levels differed between control and β1 integrin mutant glands (Fig 12B). CKIs of 
the CIP/KIP family (p21Cip1, p27Kip1 and p57Kip2) were also analyzed. The levels of p57Kip2 were similar 
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in control and mutant glands; p27Kip1 levels were slightly elevated in β1 integrin mutant mammary glands 
taken from 14-day, but not 3-day lactating mice; p21Cip1 was dramatically increased in β1-integrin mutant 
glands throughout lactation including lactation day 2 (Fig 12C & data not shown). At least at early times 
the increase in p21Cip1 might be independent of p53, which was decreased in β1 integrin mutant in 
comparison to control mammary glands (Fig 11A). There was also a significant increase in p21Cip1 
specific mRNA in glands lacking β1 integrin (data not shown). Thus, it is possible that the proliferation 
defect might be due, at least partially, to the specific increase in p21Cip1 expression.  
 
Ablation of β1 integrin impairs focal adhesion signaling 
In addition to providing adhesion, engagement of β1 integrins promotes the formation of signaling 
complexes that regulate F-actin accumulation; the best characterized being the focal adhesions. We 
examined focal adhesion kinase (FAK) whose recruitment to these structures induces downstream 
signaling (Schlaepfer, 1998) and paxillin a focal adhesion associated protein that is a target for active 
FAK and Src kinase. FAK activity, as measured by phosphorylation on Tyr397, an autophosphorylation 
site, was decreased in β1 mutant glands (PY397 FAK, Fig.11C). Phosphorylation of paxillin on Tyr118 
was also decreased in β1 mutant glands (Fig11C).  FAK expression level was slightly decreased in 
mutant glands taken at day 14 of lactation (Fig.11C). 
 
 
Loss of either β1 integrin or FAK induces p21Cip1 upregulation in primary mammary cells  
To investigate further the link between β1 integrin, FAK and p21Cip1, we used primary mammary cells 
from Itgβ1flox/flox and from FAKflox/flox mice. Primary cells were prepared from pregnant females and 
cultures were infected with an Adeno-Cre virus or a control Adeno-βgal control virus. Cell lysates from 
2-day infected cultures were examined by western analyses for β1 integrin, FAK and p21Cip1 levels. The 
nearly 100% infection efficiency was attested to by the low levels of both β1 integrin and FAK in Adeno-
Cre infected cells (Fig 13 panels a, b & c). Importantly, each of these cultures showed a strong induction 
in p21Cip1 levels (Fig 13 panels a, b& c). As we observed in vivo, p27Kip1 levels were unaffected by loss of 
β1 integrin in primary cultures.  Furthermore, similar to in the in vivo observation, we found PY-397 
FAK was decreased in the primary cells after loss of integrin β1 (Fig13 panels b). Thus, intact mammary 
glands as well as isolated primary cells display elevated p21Cip1 expression and impaired focal adhesion 
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signalling in the absence of β1 integrin. Moreover, loss of FAK function also leads to upregulation of 
p21Cip1 expression.  
 
Absence of p21Cip1 rescues impaired BrdU incorporation in mammary cells of β1 integrin mutant 
mice. 
To examine if p21Cip1 up-regulation was responsible for the proliferation defect observed in β1 integrin 
mutant mammary glands, p21Cip1 -/- mice were crossed with β1 integrin mutant mice to generate double 
mutant mice. Western Blot analysis was used to examine the expression of β1 integrin and p21Cip1 in 
each mice (Fig.14A). BrdU was injected into lactating females and paraffin sections from isolated 
mammary glands were stained with an anti-BrdU specific antibody (Fig.14B). There was a statistically 
significant increase in DNA synthesis in double mutant glands in comparison with the integrin β1 
mutants (Fig.14B). 
 
Using in vitro model to further investigate the proliferation mechanisms: the anti-proliferative 
effect of β1 integrin loss in MDA-MB-231 cells is dependent upon p21Cip1 up-regulation 
To investigate directly if loss of β1 integrin blocks proliferation via p21Cip1 induction, we used as a model 
MDA-MB-231 breast cancer cells, in which β1 integrin is known to play an important role in the tumor 
cell phenotype (Trusolino et al., 2000; Wang et al., 2002). Transfection of β1 integrin specific siRNA 
strongly reduced expression of the integrin, relative to the control LacZ siRNA-transfected cells (Fig 
15A). β1 integrin knockdown cells had higher levels of p21Cip1 protein (Fig 15A) and mRNA (Fig 15B), 
relative to controls. Immunofluorescence revealed that PY-397-FAK was present on the membrane focal 
adhesions in control cells (Fig 15A, upper panel), and in β1 integrin knockdown cells PY-397-FAK was 
relocalized to the cytoplasm (Fig 16A, lower panel). To link FAK to p21Cip1 induction, we used the FAK-
related non-kinase (FRNK), composed of the noncatalytic carboxyl-terminal protein-binding domain of 
FAK, which acts in a dominant negative manner to attenuate FAK activity (Richardson et al., 1997). 
MDA-MB-231 cultures were transfected with a p21Cip1 promoter luciferase reporter plasmid (el-Deiry, 
1993), together with the FRNK-encoding plasmid and luciferase activity was measured; β1 integrin 
knockdown cells were also examined in a parallel experiment. The results showed that down-regulation 
of β1 integrin expression or interfering with FAK signaling led to a 2-fold and 5-fold increase in p21Cip1 
promoter activity, respectively (Fig. 16B, upper & lower panels).  
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Importantly, loss of β1 integrin had a strong anti-proliferative effect on MDA-MB-231 cells. In 
comparison to control cultures, a FACS analysis revealed that β1 integrin knockdown cells had a 41% 
increase in G1-DNA content and a 90% decrease in BrdU incorporation (Fig 17C, β1); a cell count 
showed that there was a  > 50% decrease in cell number (Fig 17B, β1). In the next experiment, specific 
siRNA was used to probe for the role of p21Cip1 in the anti-proliferative response observed in β1 integrin 
knockdown cells. To accomplish this, cells were transfected with siRNAs for β1 integrin and for p21Cip1, 
either alone or in combination. Western analyses were used to assess transfection efficiencies (Fig 17A), 
and DNA content and cell number were monitored (Fig 17 B& C). Knockdown of p21Cip1 had essentially 
no effect on G1-DNA content, BrdU incorporation (Fig 17C p21 vs. control) or cell number (Fig 17B, 
p21 vs. LacZ). Cells with β1 integrin and p21Cip1 knockdown were rescued from the effect of β1 integrin 
loss. More specifically, G1 DNA content decreased from 88% in β1 integrin knock-down cells to 70% in 
double knock-down cells (56% rescue, based on 47% G1 DNA in control cells); BrdU incorporation 
increased from 4% in β1 integrin knock-down cells to 19% in double knock-down cells (54% rescue, 
based on 39% in control cells) and cell number was rescued by approximately 50%. These results suggest 
that β1 integrin controls proliferation by maintaining low expression of p21Cip1; in the absence of β1 
integrin signaling, p21Cip1 expression is induced transcriptionally and cells accumulate in the G1 phase of 
the cell cycle.  
 
Loss of β1 integrin leads to a defect in alveolar cell proliferation during a second pregnancy 
The phenotype resulting from β1 integrin loss was more pronounced in glands from mice undergoing a 
second pregnancy.  Wholemounts and H & E stained sections both showed that the lobulolalveolar units 
were sparser in the β1 integrin mutant glands compared to control glands (Fig 18A, panels a vs. b and c 
vs. d). Following involution, it has been shown that a portion of WAPCre expressing cells bypass 
apoptosis and remain in the remodeled mammary gland, where they give rise to clonal populations of 
alveolar cells during subsequent pregnancies (Wagner et al., 2002; Ludwig et al., 2001). Considering this, 
we hypothesized that the sparse phenotype was due to the presence of progenitor cells with a recombined 
Itgβ1 gene in the involuted gland, which had an impaired ability to proliferate during the second 
pregnancy. We examined this further using the mammary transplantation technique, a method to 
functionally identify mammary stem cells by measuring their in vivo outgrowth potential (Kordon and 
Smith, 1998; Smith, 1996). Pieces of mammary tissue from β1 integrin mutant mice or control mice were 
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isolated from 3-day lactating glands, a time of maximal Cre expression. These tissue pieces were 
transplanted into the cleared fat pads of recipient syngeneic mice (6 mice for each genotype). After 10 
weeks, recipient females were mated and at pregnancy-day 16, they were sacrificed and mammary gland 
whole mounts were prepared. As expected, control transplants were able to grow out and form ducts 
and/or alveolar structures (5/6) (Fig 18B, panel a). In striking contrast, transplanted tissues from b1 
integrin mutant mice were unable to grow in recipient mice (6/6). These results strongly suggest that 
alveolar progenitor cells have an impaired ability to proliferate in the absence of β1 integrin. 
 
β1-integrin play multiple roles in the development of mammary gland 
Overall, we found β1 integrins have key roles at several stages during the development and function of 
the mammary gland (Fig.19). Firstly, It could regulate the proliferation of mammary alveolar cells at 
early lactation. During involution and tissue remodeling, it might participate in the mammary progenitor 
cell proliferation and/or survive. As an important cell adhesion receptor, it could involve in the glandular 
morphogenesis and maintenance of mammary gland integrity throughout lactation. 
 86
Fig.1 Genetic ablation of β1 integrin in mouse mammary gland.A 
C 
 
 
ko 1.3kBFigure 1. Genetic ablation of β1 integrin in mouse mammary gland. (A) Schematic representation of the 
floxed β1 integrin allele (a) and the recombined allele (b). The first coding exon of the β1 integrin allele was 
flanked by two loxP sites (Graus-Porta et al., 2001). The PCR primers for detection of the floxed and 
recombined allele and the product size are indicated. (c) The structure of the WAPiCre transgene is shown. 
Transgenic mice were generated using a P1-derived bacterial artificial chromosome (PAC) harboring the 
WAPiCre gene with at least 25 kb of 5' flanking sequences.(Wintermantel et al., 2002). (B) Cre mediated 
recombination was analyzed by PCR using genomic DNA from 3-day lactating mammary glands of control 
(Itgβ1flox/flox;WAPiCre-/-) or β1-integrin mutant (Itgβ1flox/flox;WAPiCre+/-) mice.  The 2.1 and 1.3 kB bands 
correspond to the β1 floxed (fl) and the β1 integrin recombined (ko) alleles, respectively. (C). At lactation day 
3, β1 integrin and α-tubulin expression levels were analyzed by western blotting on tisse lysates. 
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Fig.2 Specific ablation of β1 integrin in lactating mammary luminal epithelial cells 
Control Mutant B A Control Mutant 
Figure 2. (A) WAPiCre displays tightly controlled expression in luminal epithelial cells. Paraffin sections from virgin 
(a) and 3-day lactating (c) control mice or virgin (b) and 3-day lactating (d) β1 integrin mutant mice were analyzed for
Cre recombinase expression using a specific antiserum. The black arrow in (d) indicates Cre positive cells. (B) Efficient 
and specific ablation of β1 integrin in luminal epithelial cells. Frozen sections of mammary glands from 3-day-
lactating control (e & g) and β1 integrin mutant  (f & h) mice were stained for β1 integrin. The pictures in g & h were 
taken at a higher magnification. The white and yellow arrows indicate β1 integrin staining of luminal and myoepithelial 
cells, respectively. 
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Fig.3 Effect of β1 integrin deletion on adhesion of primary mammary epithelial cells. 
Figure 3 Loss of β1 integrin in luminal cells leads to impaired adhesion on laminin. Primary mammary cells were 
prepared from 5-day lactating control and β1 integrin mutant females and used immediately in adhesion assays. 7 x 
104 primary cells were plated on 96 wells pre-coated with poly-D-Lysine (PDL), collagen type I (CI), fibronectin 
(FN), laminin (LN) and gelatin. After one hour, unattached cells were washed away, and adhered cells were fixed, 
stained with crystal violet, solubilized in 1% SDS and absorbance at 595 nm was read. The error bars represent 
standard deviation of the mean of triplicate samples within one experiment. 
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Fig.4  Pup Weight Analysis. 
B 
A 
Figure 4. Average body weight increase of pups nursed by three control and three 
mutant mice during first lactation stage (A) and second lactation stage (B).  
Each data point represents the average of 3 litters each with 8 pups (n=24,a) or 6 
pups (n=18,b). Data are means±S.D. This assay is independent of the genetic 
background 
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Fig.5 Milk expression pattern. 
A B 
C 
Figure 5. (A) Milk expression pattern at first lactation day 5 and day 14. The milk proteins (WAP and β-casein) 
are indicated by arrows. (B) Western Blot analysis of p-Stat5, stat5, p-Jak2 and Jak2 protein expression at 
lactation day 3 and lactation day 14. (C) Mice were milked at lactation-day-5 and lactation-day-14. And the 
secreted milk from the fourth mammary glands were collected and calculated at these two time points. 
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Fig.5 Milk expression pattern. 
 DFigure 5. (D) ErbB4 staining was checked on mammary sections at first lactation day 3 and day 14. Note the 
nuclear localization of erbB4 at lactation day 3. At lactation day 14 it concentrated on the membrane and at this 
time the staining of erbB4 is more diffused in the mammary gland sections of mutant mice.  
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Fig.6 Whole mount analysis of control and β1 integrin mutant mammary glands. 
Figure 6. Whole mount analysis of mammary glands taken from control(a;e;c;g) and β1 integrin mutant(b;f;d;h) mice 
during the first (a-d) or second (e-h) round of pregnancy(a;b;e;f) and lactation(c;d;g;h). 
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Fig.7 Loss of integrin β1 leads to adhesion defects and detachment of mammary epithelial cells. 
A 
14.3±2.71.3±0.3
B 
Figure 7. Mammary glands were taken from control- and β1 integrin mutant mice during the first (A) or second 
(B) round of pregnancy and lactation, and paraffin sections were prepared and stained with H & E. (A) The 
mammary glands were from mice at: day 16 of pregnancy (a, b, g & h), lactation day 1 (c, d, i & j), and day 5 (e, f, 
k & l). (B) The mammary glands were from mice at lactation day 5 (a-d). The black arrows in (A) panels f & l and 
(B) panels b and d, indicate irregularities in the alveolar architecture; the yellow arrows in (A) panels f & l, and (B) 
panels b & d, indicate cells shed into the lumen of β1 integrin mutant mice, a phenotype that became starting at 
lactation day 3 of the first pregnancy. (A) panels g-l and (B) panels c and d, were taken at 2X higher magnification 
than (A) panels a-f and (B) panels a and b. White boxes in k&L indicate the quantification of the displaced cells 
(including shed and procuding cells) from 3 pairs of control and mutant mice. 
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Fig.8 Immunostaining of the molecular markers on the mammary gland sections. 
Figure 8. The Frozen sections of mammary glands from 5-day-lactating control mice (a, c, e, g, i & k) and 
β1 integrin mutant mice (b, d, f, h, j & l) mice were stained for: (a & b) α-smooth-muscle actin (20x); (c & 
d) the sodium phosphate cotransporter isoform, Npt2b (20x) (e & f) Laminin-1 (20X); (g & h) E-cadherin 
(60X); the arrows in panels f & h indicate cells detached from the BM; (i & j) β4 integrin (120X); the 
arrowhead in panel j shows relocalization of β4 integrin from the basal surface (white arrow) to the apical 
surface in mutant cells; (k & l) F-actin (100X); the arrow shows stress fibers in luminal cells from control 
mice. In panel l actin staining is localized not only on basal but also lateral surfaces of mutant cells. 
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 Fig.9 There is no increase of apoptosis in integrin β1 mutant glands during lactation. 
Figure 9. Sections prepared from β1 integrin mutant mammary glands of 14-day lactating females were analyzed by 
electric microscopy. In (a) a single luminal epithelial cell that is detaching from its neighbors is shown; the nucleus is 
labeled N. The black arrow and arrowhead indicate caseins micelles and a lipid droplet, respectively (X5000). In (b) a 
detached cell in the lumen is outlined in white. Another cell (arrow) is in the process of detaching. Neither nucleus (N) 
is apoptotic (X2500). 
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Fig.10 Loss of β1 integrin could slightly increase the apoptosis rate during involution. Figure 10. Paraffin sections from day 1 involuting mammary glands from control- (a & c) and β1 integrin mutant (b & 
d) mice were stained with hematoxylin and eosin (a & b) or were TUNEL-stained to detect apoptosis (c & d). In a & b 
cells shed into the lumen (black arrows) were quantified (insert on right) in sections from 3 pairs of control and mutant 
mice.  In each case, 900-1200 nuclei per section were counted. Data are means±S.D. In c & d the black arrows show 
positive TUNEL staining; the green arrows show shed cell that are negative for TUNEL staining. Tunel positive cells 
were quantified (insert on right) in sections from 3 pairs of control and mutant mice.  In each case, 900-1200 nuclei per 
section were counted. Data are means±S.D.   
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Fig.11 Changes of signalling pathways after loss of β1 integrin. 
Figure 11. Analysis of proteins from 3- and 14-day lactating mammary glands. Western blotting revealed the 
levels of (A).  p-Stat3, stat3, Bax and p53; (B).p-GSK3β, GSK3β, p-AKT47,Akt; (C). Tyr397 FAK (PY397), 
FAK, vinculin, Tyr118 Paxillin (PY118) and paxillin; (D). E-cadherin, β-catenin and α-tubulin protein 
expression. 
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Fig.12 Loss of β1 integrin leads to reduced mammary cell proliferation. 
Figure 13. (A) For DNA labeling, 2-day lactating females were injected with BrdU 2 hr prior to sacrifice. Paraffin sections 
of mammary glands from control (a) and mutant β1 integrin mutant (b) mice were incubated with a monoclonal antibody 
against BrdU and stained with the ABC staining system. BrdU-positive nuclei (black arrows) were quantified (c) from 3 
pairs of control and β1 integrin mutant 2-day lactating females. In each case, 900-1200 nuclei per section were counted. 
Data are the mean±S.D. (B & C) Analysis of cell cycle regulators from 3- and 14-day lactating mammary glands of control 
(C) and β1 integrin mutant (M) mice. (B) Western blotting analysis revealed that the level of Cyclins B1 and E and CDK2 
were not altered in mutant mice; while Cyclin D1 expression was slightly increased. (C) Western blotting analysis revealed 
that the levels of p27Kip1 and p57Cip2  were not altered in mutant mice at lactation day 3; p27Kip1 level was increased at 
lactation day 14; p21Cip1 level was strongly increased throughout lactation; keratin 18 was used to control loading. 
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Fig.13 Loss of β1 integrin or FAK leads to upregulation of p21 in primary cells. 
Figure.13. Loss of b1 integrin or FAK in primary mammary cells leads to upregulation of p21Cip1. 
Primary mammary cells were prepared from pregnant β1flox/flox mice (A,B) or pregnant FAKflox/flox mice 
(C) and infected with Adeno-β gal control virus or with Adeno-Cre-virus. The infection efficiency 
was nearly 100%, as attested to by staining parallel cultures with a Cre specific antibody. Cell lysates 
were prepared and analyzed by western blotting. The membranes were probed with antiserum specific 
for: (A) β1 integrin, Cre, p21Cip1 and p27Kip ; Erk2 was used to control loading; (B) β1 integrin, Cre, 
PY-397 FAK and FAK. (C) PY-397 FAK, FAK, p21Cip1 and Cre; actin was used to control loading. 
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Fig.14 Absence of p21Cip1 rescues the proliferation defect in β1 integrin mutant mice 
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Fig.15 Loss of β1 integrin leads to upregulation of p21 in MDA-MB 231 cells. 
Figure 15. β1 integrin- or control lacZ- siRNA was transfected into MDA-MB-231 cells: after 4 days,
(A) cell lysates were analyzed by western blotting and membranes were probed with β1 integrin, p21Cip1
and α-tubulin specific antibodies; (B) total RNA was isolated and p21Cip1 and actin RNA levels were 
quantified using specific PCR primers. 
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Fig.16 Loss of β1 integrin leads to mislocalization of p-FAK in MDA-MB 231 cells. 
Figure 16. (A) After 3 days cells transfected with LacZ siRNA (upper panel) and β1 integrin siRNA (lower panel) 
were stained with PY-397-FAK antiserum. The boxed area is shown enlarged on the right. (B) (Upper panel) cultures 
were transfected 2 days with control LacZ siRNA or β1 integrin specific siRNA; then the WWP-Luc reporter plasmid 
plus control renilla plasmid were transfected and 2 days later p21Cip1 promoter activity was measured. (Lower panel) 
p21Cip1 promoter activity was measured 2 days following transient transfection of a FRNK expression plasmid (DN-
FAK) or the control pCDNA3 plasmid together with the WWP-Luc reporter plasmid and the control renilla plasmid. 
In each experiment luciferase activity was normalized to the Renilla internal control. 
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Fig.17 p21Cip1 was responsible for the anti-proliferative effects of β1 integrin loss. 
Figure 17. (A & B) Four days after transfection of siRNA for LacZ, β1 integrin, p21Cip1  + LacZ, or β1 integrin + 
p21Cip1 (A) MDA-MB231 cell lysates were analyzed by western blotting and membranes were probed with p21Cip1, 
β1 integrin, and α-tubulin specific antibodies, or (B) cells were counted in triplicate. Data are presented as the mean
±S.D.  
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 Fig.17 p21Cip1 was responsible for the anti-proliferative effects of β1 integrin loss.Figure 17. (C) MDA-MB231 cells were transfected with LacZ siRNA and/or β1 integrin siRNA for 3 days, then 
labeled with BrdU for 1hr before collecting. Harvested cells were stained with anti-BrdU-FITC to quantitate cells 
in S-phase and with 7AAD to stain DNA before flow cytometry was performed. The percent cells in G1 and G2-M 
is indicated in the top of each panel; the percentage of cells that incorporated BrdU is indicated in the box. Data 
are presented as the mean±S.D.  105
 Fig.18 A possible role for β1 integrins in the maintenance of mammary stem cells. 
Figure 18. (A) Whole mount analysis (a-b) or histological analysis (c-d) of mammary glands taken from control 
and β1 integrin mutant females at day 16.5 of a second pregnancy.  (Magnifications: a & b - 6X; c & d -10X). (B) 
Whole mount analysis of mammary transplant outgrowths. Pieces of mammary tissue taken from 3-day lactating 
control mice (a) or β1-integrin mutant mice (b) were transplanted into cleared fat pads of 21-day old syngeneic 
females. After 10 weeks the recipient female mice were mated and at pregnancy day-16 glands were removed and 
examined by whole-mount analysis (8X).  
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Fig.19 β1 integrins play multiple roles in the development of mammary gland. 
Figure 19. A model showing β1 integrins have key roles at several stages during the development and 
function of the mammary gland. Firstly, It could regulate the proliferation of mammary alveolar cells at 
early lactation. During involution and tissue remodeling, it might participate in the mammary progenitor cell 
proliferation and/or survive. As an important cell adhesion receptor, it could involve in the glandular 
morphogenesis and maintenance of mammary gland integrity throughout lactation. 
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Conclusion 
 
• Integrin β1 was specifically deleted in the mammary luminal secretory cells after cre 
mediated recombination. 
• In the absence of β1 integrin, the alveolar architecture was impaired and cells were shed 
into the lumen. 
• The normal proliferative burst at the start of lactation was severely reduced in the absence 
of β1 integrin, which correlated with specifically increased p21Cip1 expression. 
• Ablation of β1 integrin impairs focal adhesion signaling 
• In mammary primary cells, ablation of β1 integrin or FAK could impair focal adhesion 
signalling and upregulate p21cip1 expression. 
• Ablation of β1 integrin in a p21Cip1 null background partially rescued the proliferative 
defect in vivo. 
• In MDA-MB-231 cells, loss of integrin β1 caused a G1 block and p21cip1 upregulation, and 
knock down of p21cip1 could partially rescue this proliferation defect. 
• Transplanted mammary tissue from β1 integrin mutant females failed to repopulate 
recipient mammary glands. 
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Discussion 
 
In this report we present the first detailed molecular analysis of mice with a mammary gland-restricted 
disruption of the β1 integrin-encoding gene. WAPCre-mediated recombination of β1 integrin occurred 
specifically in luminal alveolar cells in late pregnancy and lactation, a time when several phenotypes 
became apparent. Firstly, luminal secretory cells of many alveolar structures became disorganized. Cells 
became detached from the basement membrane and were shed into the lumen of the gland; suprisingly, 
these cells were not apoptotic. Secondly, luminal cell proliferation was reduced strongly and p21Cip1 levels 
were elevated dramatically in the β1 integrin mutant glands. A link between β1 integrin, FAK, p21Cip1 and 
decreased cell proliferation was established not only in vivo, but also in vitro in both primary mammary 
cells and an established cell line.  Finally, transplanted mammary tissue from β1 integrin mutant mice was 
unable to grow in recipient hosts, suggesting a possible role for β1 integrins in stem cell maintenance. 
Based upon these results we propose that β1 integrins have key roles at several stages during the 
development and function of the mammary gland (Fig.19).  
The major functions of integrins are to connect the ECM to the cytoskeleton in order to propagate 
structural order between the two and to activate signalling cascades controlling cellular behavior 
(Giancotti and Tarone, 2003). The phenotypes we present here are consistent with these two main 
functions. We have also observed some differences to published results, e.g., with respect to apoptosis and 
laminin deposition following β1 integrin loss (Faraldo et al 1998). These variations are very likely due to 
the strategy we employed, for example genetic compared to implantation of β1 blocking antibody-
containing pellets (Klinowska et al., 1999) or a DN approach (Faraldo et al 1998). Furthermore, the use of 
a different Cre transgene has allowed the effect of β1 integrin loss to be examined at another 
developmental stage. Interestingly, ablation of β1 integrin using the MMTV-Cre transgene, which is 
expressed in the virgin gland, did not lead to alterations in mammary gland proliferation (White et al., 
2004). Similar to our results, the MMTV-dominant-negative β1 transgenic strain (Faraldo et al 1998) also 
displayed a proliferation defect at lactation; however, the responsible cell cycle regulator was not 
identified.  
 
Functional differentiation was normal in integrin β1 mutant glands 
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Although we observed function impairment of mammary gland in β1 integrin mutant mice as measured by 
pup weight ananlysis (Fig.4), based upon molecular and morphological criteria, functional differentiation 
of mammary glands lacking β1 integrin was normal. Although there was a slight decrease in Jak2 and 
Stat5 activation (Fig 5B), this did not lead to alterations in milk protein gene expression (NL, unpublished 
observations), which is also consistent with the apical expression of Npt2b, a marker of functional 
mammary secretory cells (Fig.8, panel c&d). Furthermore, casein micelles and milk-fat droplets are 
evident in the milk of β1 integrin null females (Fig 9A). These results were to some extent unexpected 
based upon published in vitro (Barcellos-Hoff, 1989)(Streuli, 1995) and in vivo (Faraldo, 1998) results. 
However, it has been observed that many organs are able to differentiate in the absence of β1 integrin 
(Bouvard, 2001). For example, keratinocytes display altered morphology and reduced proliferation in the 
absence of β1 integrin, however, are still able to terminally differentiate (Brakebusch, 2000). 
Moreover, WAPicre expression commences at late-pregnancy and it is possible that in most of the luminal 
cells, the differentiation controlling genes are already turned on before the recombination occurs. 
Furthermore, the integrin β1 is only absent in the luminal epithelial cells and still remained in 
myoepithelial cells in the mutant glands. Although the luminal epithelial cells are main functional cell 
type, the myoepithelial cells which help in milk injection still contain β1 integrin and its interaction with 
the basement membrane may play a role in mataining the differentiation of the organ. 
Thus, we favor the hypothesis that the observed function impairment of the mammary gland in β1 integrin 
mutant mice (Fig.4) is not due to a differentiation defection, but due to the decreased mammary epithelial 
proliferation and impaired mammary gland integrity (disscussed below).  
 
β1 integrin deletion results in loss of epithelial integrity 
 
1. Detachement from the basement membrane 
We show here for the first time that β1 integrin ablation triggers a loss of epithelial integrity in the 
alveolar structures of the lactating mammary gland. Alterations included areas of cells protruding from the 
luminal surface and the appearance of shed cells in the lumen, while basement membrane was normal in 
β1 integrin mutant glands.  
It is well known that one of the main functions of integrins is to mediate adhesion between the cells and 
the extracellular matrix.  Indeed, in the adhesion assay, we found that primary luminal epithelial cells 
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prepared from β1 mutant mammary gland showed defective adhesion specifically on laminin, one of the 
main components of the basement membrane. Therefore, it is not surprising that in vivo cells start to be 
shed after lossing this anchor. For example, skin and hair follicle integrity is crucially dependent on β1 
integrin expression on keratinocytes (Brakebusch, 2000). However, in mammary gland, this event only 
became visible after the lactation-day-3, at that time the WAPiCre has the peak Cre expression, and 
became very obvious after lactation day 5, when about 14% of the luminal cells were in the process of 
shedding or lost in the lumen (Fig.7h). We suggests that this phenotype is not a simple event happening 
only because cells have become detached, but may need other signals to occur.  For example, we suspect 
that integrin β4 may play some roles to protect cells from being shed because more hemi- desmosomes 
could be formed after loss of integrin β1 because integrin β4 could compete α6 subunit (to form hemi-
desmosomes) with integrin β1.  
 
2. Relocalization of integrin β4 subunit 
In the mammary epithelial cells, there are two main integrin β subunits, integrin β1 and integrin β4. 
Integrin β1 is present at the basolateral surfaces of both myoepithelial and luminal epithelial cells. The β4 
is only present at the basal aspect of these two cell types. After ablation of integrin β1, we observed that 
luminal and myoepithelial cells of control and β1 integrin mutant glands display β4 integrin on their basal 
surfaces (Fig.8i). In addition β4 integrin was detected on the apical surface of some luminal cells in the β1 
integrin mutant glands (Fig.8j). The mislocalization of integrin β4 was also observed in dominant negative 
integrin β1 transgenic mice where integrin β4 was revealed at the basal cell surface and, in addition, co-
localized with laminin at the lateral surface of luminal epithelial cells (MA.Glukhova, 1998). We didn’t 
observe the relocalization of laminin. The relocalization of integrin β4 revealed defects in cell polarization 
and may suggest the importance of integrin β1 in cell–cell junctions. 
  
3.Decreased cell-cell association 
The importance of β1 integrin in promoting both cell-extracellular matrix and cell-cell interactions is well 
known from, for example, the kidney (Ojakian and Schwimmer, 1994; Schoenenberger et al., 1994) and 
keratinocytes (Symington et al., 1993; Larjava et al., 1990). In control mammary glands, β1 integrin was 
present on basal and lateral surfaces of luminal cells; its absence in the mutant glands very likely 
contributes to weakened cell-cell interactions. E-cadherin is another protein that might be involved in 
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maintenance of alveolar integrity. In control glands, E-cadherin was found on lateral surfaces of most 
luminal cells (Fig.8g), while in mutant glands many luminal cells had little or no staining, reflecting the 
decrease in E-cadherin levels (Fig.11D). Conditional knock-out of E-cadherin in the mouse mammary 
gland revealed that E-cadherin is a survival factor since massive cell death was observed at parturition in 
the mutant glands (Mechanisms of Dev. 115(2002) 53-62, Rolf Kemler, 2002). Furthermore, β-catenin 
expression was not changed at early lactation but was decreased at lactation day 14 (Fig.11D). Integrin-
dependent BM adhesion is known to reinforce E-cadherin cell-cell adhesion (Schreider et al., 2002) and 
catenin complex formation (Weaver et al., 1997). There was also a decrease in the tight junction protein 
ZO-1 late in lactation (data not shown), which might be a consequence of reduced E-cadherin levels since 
assembly of tight junctions depends upon E-cadherin recruitment to adherens junctions (Cereijido, 2000) 
Thus, these data suggest that in the mammary gland β1 integrin function has an essential role in normal 
tissue architecture via its interactions with other adhesion complexes.  
 
4.Interferance of actin cytoskeleton 
Phalloidin was used to visualize actin, since β1 integrins connect the ECM to the actin cytoskeleton. Actin 
stress fibers running along the basal surface of the cells were evident in sections from control glands 
(Fig.8, panel k). In contrast, there were no stress fibers evident in β1-integrin mutant glands. Furthermore, 
strong actin staining was also evident in some lateral and apical surfaces (Fig.8, panel l), suggesting that in 
the absence of luminal β1 integrins, the actin cytoskeleton has become disorganized. Integrin-dependent 
BM adhesion is known to cooperate in F-actin cytoskeleton organization (Schreider, 2002) (Wang, 1999) 
Thus, these data suggest that in the mammary gland β1 integrin function has an essential role in normal 
tissue architecture via its interactions with other adhesion complexes and with the actin cytoskeleton.  
 
5. Is the impaired milk secretion due to the change of the structural integrity? 
Interestingly, functional analysis showed that the pups fed by mutant mothers had reduced pup weight in 
comparison to the pups fed by wild type mothers. However, functional differentiation as measured by milk 
protein expression was normal in integrin β1 mutant glands, while preliminary data showed that the milk 
secretion in mutant glands might be impaired. Based on the functional analysis and the structural integrity 
results, we suggest that the reduced weight observed in pups nursed by mutant mothers might be due to 
the impaired milk secretion. This impairment in turn might be caused by the altered structural integrity of 
the alveoli in mutant mammary glands. 
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 Loss of β1 integrin is not sufficient to trigger apoptosis in alveolar cells.   
Despite the evidence for weakened cell-BM interactions in the absence of β1 integrin, there was no 
obvious increase in apoptotic cells during lactation. Even cells shed, or in the process thereof, were alive, 
as attested to by their nuclear appearance and the lack of TUNEL staining (Fig 9 & data not shown). 
These results are in contrast to those described for primary mammary cells, which are dependent upon β1 
integrin signaling for survival (Boudreau et al., 1995; Streuli et al., 1995) as well as transgenics expressing 
the DN β1 transgene (Faraldo et al 1998). In a similar vein, in the absence of β1 integrins basal 
keratinocytes underwent in vitro, but not in vivo apoptosis (Brakebusch et al., 2000). In vivo, there is 
likely to be a balance, which is well attuned to the environment, between apoptotic and anti-apoptotic 
factors. Primary cells could be more susceptible to apoptosis since they are removed from their normal 
environment. Indeed, microarray analyses carried out on mammary glands from 3-day lactating mice, a 
time when luminal cell-shedding began, revealed that in mutant glands anti-apoptotic genes, such as 
thioredoxin-dependent peroxide reductase (Ueda et al., 2002) were up-regulated, and pro-apoptotic genes 
including caspase-11 (Hisahara et al., 2000) were down-regulated (NL, data not shown). Western Blotting 
analysis also revealed the alteration in the regulations of two pro-apoptotic genes: STAT3 and Bax. 
STAT3 is pro-apoptotic and is a crucial mediator of post-lactational regression (Chapman et al., 1999). 
Using conditional gene targeting, it has been shown that in the absence of STAT3, involution is delayed 
for several days, owing to a reduction in apoptosis (Humphreys RC, et. al. 2002). Bax, a proapoptotic 
member of the Bcl-2 family of proteins, was first discovered in a screen of proteins that exhibited binding 
interactions with Bcl-2. Bax is likely to have pore-forming activity in the mitochondrial membranes, 
subject to control or prevention by association with specific antiapoptotic molecules (especially Bcl-2 and 
Bcl-x ), related to its ability to bind to BH-3 domain-only containing Bcl-2 family member proteins, and 
induce the release of mitochondrial cytochrome c (
L
Willis S. et al. 2003). In the absence of integrin β1, the 
expression of Bax was increased throughout lactation, while the phosphorylation of STAT3 was decreased 
throughout lactation (Fig.11, panel A). We also examined the serine/threonine kinase PKB, which 
transmits survival signals triggered by integrin-mediated adhesion (Datta et al., 1999). The activity of this 
kinase was assessed using an antiserum specific for the active, phosphorylated form. There was no 
difference in the level of Ser 473 phosphorylated PKB in extracts from lactating glands of β1-integrin 
mutant mice compared to control mice. Moreover, phosphorylation of Ser 9 of glycogen synthase kinase 
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3-β (GSK3β), a downstream target of PKB, was not altered in β1-integrin mutant mammary glands 
(Fig.11, panelB). 
Finally, it has been documented that only a combination of unfavorable conditions induces apoptosis. For 
example, HC11 mammary cells when released from a laminin-rich BM (Chammas et al., 1994) become 
apoptotic only if exposed to serum-free medium; EGF-containing medium allowed survival of the released 
cells (Merto et al., 1997). In vivo, it is possible that other signals combined with loss of BM attachment 
could abolish the balance and promote apoptosis. Indeed, at the start of involution, there was a slight 
increase in TUNEL-positive cells in β1 integrin mutant glands, compared to control glands (Fig.10). The 
level of the pro-apoptotic Bax protein was also elevated in mutant glands (NL, unpublished observations). 
Using a conformation specific antibody, it was observed that at the start of involution there is a decrease in 
β1 integrin-BM interaction (Prince et al., 2002). Building upon these results and our current observations, 
Our results suggest that in vivo, cell detachment can be uncoupled from apoptosis and loss of β1 integrin 
in mammary luminal cells is not sufficient to trigger cell death. 
 
β1 integrins have a key role in the proliferation of mammary epithelial cells in vivo and in culture 
 
1. Integrins and proliferation control 
Cells require anchorage to ECM to proliferate; β1 integrin is known to have an important role in 
modulating the activity of signaling pathways that regulate proliferation in many cell types, such as in 
basal keratinocytes (Brakebusch, 2000 & more details in introduction part I and III). In addition to the 
alveolar integrity impairment, the other major phenotype observed in β1 integrin mutant mice was a 
proliferative defect. Proliferation of secretory luminal cells occurs during pregnancy and early in lactation. 
We did not observe a consistent decrease in the number of BrdU incorporating cells at mid-pregnancy (NL, 
unpublished observations), likely due to the fact that WAPCre expression only commences at this 
developmental stage. However, our results clearly show that early in lactation there is a strong decrease in 
alveolar cell division in the absence of β1 integrin (Fig 12).  
 
2. CDK inhibitors  
Cell cycle progression is controled by cyclins and CDKs. A key event in the G1 phase of cell-cycle 
progression is hyperphosphorylation of the retinoblastoma (Rb) protein by active cyclin-CDK complexes, 
leading to release of E2F-family transcription factors from their complex with Rb. In addition to cyclin 
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binding, the activity of the G1 phase cyclin-CDKs is affected by the action of specific CDK-inhibitors 
(CKIs). It was shown that integrin signals are necessary for cells to traverse the cell division cycle, a loss 
of its signaling correlates well with increased levels of different CDK inhibitors. β1 deficient 
chondrocytes show a defect in the G1/S phase transition, which is, accompanied by upregulation of the 
CKIs p16Ink4a and p21Cip1 (Aszodi et al., 2003). Ablation of β1 integrin in developing cerebellum revealed 
its role in cerebellar granule cell precursor (CGP) proliferation. In the absence of β1 integrin the CGP pool 
failed to expand due to p27Kip1 upregulation (Blaess et al., 2004). Here we show that there is a specific 
increase in p21Cip1 levels in lactating mammary glands from β1 integrin mutant mice. Morover, we have 
also provided in vivo evidence that p21Cip1 is responsible for the anti-proliferative effects of β1 integrin 
loss. In the absence of p21Cip1 and β1 integrin there was a partial, but statistically significant rescue in the 
proliferative defect (Fig 14). Using the MDA-MB-231 cells we also showed that simultaneous knockdown 
of p21Cip1 in β1 integrin knockdown cells partially rescued the G1 cell cycle block induced by loss of the 
integrin (Fig 17). Since we observed both upregulation of Bax and p21cip1, the downstream target gene of 
p53, throughout lactation, we also checked the expression of p53. After loss of integrin β1, the expression 
of p53 was down-regulated at early lactation and increased at late lactation. We also checked another 
target gene MDM2 and there are no difference of p-MDM2 or total protein expression between the control 
glands and the mutants. In the future it will be important to verify whether p53 play a role in the 
upregulation of p21Cip1 after loss of integrin β1. 
 
3. The role of Focal adhesion kinase (FAK) in proliferation. 
FAK plays an important role in integrin-mediated signaling (Geiger et al., 2001; Parsons et al., 2000). We 
observed that phospho-FAK levels were decreased in β1 integrin mutant mammary glands (Fig 4E). 
Paxillin, a focal adhesion associated protein is a target for tyrosine kinases that are activated as a result of 
integrin signaling after cell adhesion. FAK in association with Src, which binds activated FAK via a SH2-
Tyr397 association, phosphorylates paxillin on two major sites, one of which (Tyr118) we show here is 
strongly decreased in the β1 integrin mutant mammary glands (Fig 11C).  
Studies carried out with the transgenics expressing dominant β1 integrin also reported that the 
proliferation rate was decreased at the begining of lactation. However, they showed that this growth defect 
induced by perturbation of β1-integrin function in the mammary gland epithelium result from a lack of 
MAPK activation via the Shc and Akt pathways, but the kinase activity of FAK was normal. In our studies, 
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we could not find consistent change in p-MAPK level (Data not shown); and the AKT pathway appears to 
be normal in mutant glands (Fig. 11b).  
We consider it likely that FAK kinase provides the link between β1 integrin, p21Cip1 and decreased 
proliferation. Firstly, using primary mammary cells from Itgβ1flox/flox and from FAKflox/flox mice we showed 
that Cre-mediated recombination of each gene led to impaired focal adhesion signalling and an increase in 
p21Cip1 expression (Fig. 13). Secondly, siRNA-mediated knockdown of β1 integrin in MDA-MB-231 cells 
led to PY-397-FAK relocalization, increased p21Cip1 expression and decreased proliferation. Expression of 
the DN FAK protein, FRNK (Richardson et al., 1997), in these cells induced the same phenotype. Finally, 
we determined that p21Cip1 was responsible for the anti-proliferative effects of β1 integrin loss since 
simultaneous knockdown of p21Cip1 in β1 integrin knockdown cells rescued the proliferative defect 
induced by loss of the integrin.  
To date there is no physiological evidence linking FAK to p21Cip1 upregulation. In fibroblast cells, FAK 
has been directly linked to cell division, which correlates with changes in the expression of cyclin D1 and 
the cdk inhibitor, p21Cip1; while cyclin D1, but not p21Cip1, was thought to be the primary functional target 
of FAK signaling pathways in cell cycle regulation (Zhao, 1998; Parsons et al., 2000). We showed here, 
both in vivo and in vitro, that β1 integrin has a key role in regulating cell cycle progression of luminal 
mammary epithelial cells, and we propose that β1 integrin signaling via FAK stimulates mammary 
alveolar cell proliferation, while in the absence of the integrin, p21Cip1 transcription is stimulated leading 
to a proliferative block. 
To date we have not found the molecular link the FAK kinase and p21cip1. A possible candidate Hic-5 , a 
LIM protein with striking similarity to paxillin, has been checked in the studies, because it was reported 
that Hic5 could shuttle between focal adhesion sites and nuclear and it functions as a potential coactivator 
for Sp1 (shibanuma, 2004). Western Blotting analysis showed that the expression of Hic-5 was increased 
in the mutant glands during lactation. However, by immunostaining, we couldn’t find obviously nuclear 
translocation of Hic-5 in both mammary sections and MDA-MB-231 cells (Data not shown).  
 
  
A possible role for β1 integrins in the mammary stem cells 
 
Our results also suggest that β1 integrin has an important role in proliferation and/or maintenance of 
mammary alveolar progenitor cells. Mammary glands taken from females undergoing a second round of 
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pregnancy showed a strong reduction in the density of lobulolalveolar units, suggesting that there is a 
reduction in the number of progenitor cells that enable rapid alveolar expansion (Fig 7A). Using the 
mammary transplantation technique, which allows a functional identification of mammary stem cells by 
measuring their in vivo outgrowth potential (Smith, 1996; Kordon and Smith, 1998), we could show that 
epithelium from β1 integrin mutant glands had a severe impairment in its ability to repopulate a mammary 
fat pad. These results strongly suggest that alveolar progenitors have an impaired ability to proliferate 
and/or suvive in the absence of β1 integrin. Considering the known role of integrins in maintenance of 
stem cells in, e. g, hair cell follicles (Watt, 2002), it is tempting to speculate that β1 integrins might also 
have a similar role in the mammary gland. 
Interestingly, we observed a specific upregulation of p21cip1, one of the CDK inhibitors, in the mutant 
gland. It’s known that p21cip1 is not only a protein that binds and inhibits cyclin-dependent kinases, but 
also recognized to play an important role in DNA repair, apoptosis, cellular senescence, terminal 
differentiation, and cell cycle arrest upon extracellular signalling (Poole AJ, et al. 2004).  However, the 
molecular events orchestrating the role of p21cip1 remain largely undefined in stem cells. For example, 
relative to keratinocytes from wild-type mice, keratinocytes derived from p21cip1-/-mice contain a 
significantly increased number of cells with clonogenic potential and high rates of attachment, two 
interrelated properties which have been directly connected with label-retaining stem-cell populations. 
These subpopulations have a lesser commitment to differentiation and generate all types of terminally 
differentiated keratinocytes that are present in vivo, not only in the interfollicular epidermis but also in the 
hair follicles (Topley GI, et al. 1999). On the other hand, p21cip1 was reported as a stem cell marker in 
human breast epitheial cells. These cells with Hoechst dye-effluxing “side population” (SP) properties, 
characteristic of mammary stem cells in mice, were demonstrated to be undifferentiated “intermediate” 
cells by lack of expression of myoepithelial and luminal apical membrane markers. These SP cells were 6-
fold enriched for ERα-positive cells and expressed several fold higher levels of the ERα, p21cip1 and Msi1 
genes than non-SP cells (Clarke RB, et al. 2005). In addition, p21cip1 might play a role in  stem cell surive. 
For example, p21cip1 rescues human mesenchymal stem cells from apoptosis induced by low-density 
culturing (van den Bos. et al. 1998).  Thus, we propose that loss of integrin β1 could affect the 
proliferation and/or survive of mammary stem cells, and p21cip1 might be involved in this process. 
However, the functions and mechanisms underline it needs to be determined in the future. 
 
 
 119
β1 integrins in breast cancer 
 
It is well known that integrins have important roles in cancer cell biology (Christofori, 2003). Activation 
and elevated expression of β1-integrin-coupled signaling effectors have been implicated in the induction 
of a wide variety of human cancers, including those of the breast, colon, prostate, and ovaries. In addition, 
the overexpression of β1-integrin-associated molecules such as ILK can result in the induction of 
mammary tumors in experimental mouse models (White et al. 2001). With respect to breast cancer, β1 
integrin blocking antibodies induced a morphological and functional reversion of breast tumor cells 
growing in a 3D culture model (Weaver et al., 1997). The same antibody also blocked proliferation of 
MDA-MB-231 tumor cells (Wang et al., 2002). Building on these studies, we show here that in the 
absence of β1 integrin these cancer cells arrest in G1 due to up-regulation of p21Cip1. Very recently the 
role of β1 integrin was also examined in a transgenic mammary tumor model, where it was shown that 
loss of this integrin interferes with the ability of polyoma middle T (MT) expressing mammary cells to 
proliferate (White et al., 2004). This was manifested in vivo by the absence of MT-induced 
hyperplasias/tumors in mammary glands. Based upon our results we propose that p21Cip1 upregulation in 
response to β1 integrin loss might be the mechanism underlying the block in tumor cell proliferation.  
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 Materials and Methods 
 
Antibodies  
Antibodies used for immunostaining were: α4 β1 integrin and laminin-1 (Klinowska et al., 1999), β4 
integrin (Zymed), E-cadherin (BD Transduction Laboratories), PY-397-FAK (Biosource), Cre 
(Wintermantel et al., 2002), α−smooth-muscle actin (Sigma), BrdU (Roche), Npt2b (a gift from J.Biber, 
Univ Zurich)(Hilfiker et al., 1998), phalloidin-TRITC (Sigma), FITC-labeled and TRITC-labeled 
secondary antibodies (Molecular Probes). 
Antibodies used for western analyses were: β1 integrin (Graus-Porta et al., 2001); β-catenin (BD 
Transduction Laboratories), FAK (Upstate Biotechnology); p21Cip1   p57Kip2, cyclin E, cyclin B1, Cdk2, 
Bax, P53 (Santa Cruz), cytokeratin 18 (PROGEN), α−tubulin (Neomarkers); PY-397-FAK (Biosource); 
E-cadherin, p27Kip1 (Transduction Labs), cyclin D1 (NoVoCastro); Vinculin (Sigma). .), p-stat5(Upstate 
Biotechnology), stat5a polyclonal antiserum (JBC Volume 271, Number 50, Issue of December 13, 1996 
pp. 31863-31868), 
 
Mouse strains and generation of mammary specific β1 mutant mice.  
The Itgβ1flox mouse strain, in which the first coding exon of the integrin β1 subunit gene was flanked by 
two loxP sites, has been described (Graus-Porta et al., 2001) (Fig 1A panel a).  Mice expressing Cre under 
the control of the whey acidic protein (WAP) gene promoter harbor a P1-derived bacterial artificial 
chromosome (PAC) carrying the improved coding sequence of Cre recombinase (WAPiCre) 
(Wintermantel et al., 2002) (Fig. 1A panel c). Itgβ1flox/flox mice were mated with mice heterozygous for the 
WAPiCre transgene on a Itgβ1flox/+ background. Offspring were genotyped by PCR analysis using 
genomic DNA prepared from tail biopsies. Littermates with the genotype Itgβ1flox/flox; WAPiCre-/- 
(referred to as control mice) or Itgβ1flox/flox; WAPiCre+/- (referred to as β1-integrin mutant mice) were 
used for all analyses.  β1-integrin mutant mice were generated in accord with Mendelian ratios. For the in 
vivo rescue experiment, p21Cip1 null mice (Jackson Laboratory) were crossed with Itgβ1flox/+;WAPiCre+/- 
mice, to produce Itgβ1flox/+;WAPiCre+/-;p21+/- and  Itgβ1flox/+ ;p21+/- mice, which were further intercrossed. 
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In order to initiate forced involution, litters of at least 6 pups were removed from β1-integrin 
mutant females after 9 days of lactation (Prince et al., 2002) and the mammary glands were isolated and 
analyzed at the specified times. The mice were maintained and handled according to the Swiss guidelines 
for animal safety. 
 
Pup Weight Analysis 
We mixed newborn pups from wt or k.o. Mothers and give to eight (1st Lactation) or six (2nd lactation) 
litters to pseudo-mothers. The body weight increase was documented for each pup from lactation day 2 to 
20.  The average body weight of the litters was calculated as means土SD. 
 
Milk Annalysis 
Pups were removed for 3-4 h before milking the mothers. Mice were anesthetized with 
NARKETAN+Rompun (100µL/10 g body weight) and injected intraperitoneally with Oxytoxin (0.3IU; 
Sigma) in 200µL PBS. After a 5-10-min incubation period milk was withdrawn with a Pasteur pipette. 
Diluted milk was analyzed with 15% SDS-PAGE gel. 
 
Mammary gland whole mounts 
Inguinal mammary glands were dissected, spread onto a glass slide and fixed overnight in Tellyesnicky’s 
Fixative. The slides were rinsed in water, the tissue was defatted with acetone, hydrated through graded 
alcohol, and stained with Iron-haematoxylin for 1.5 h, then washed in water, dehydrated, and mounted.  
 
Histology and immunofluorescence  
Inguinal mammary glands were dissected, fixed in 4% paraformaldehyde in phosphate-buffered saline 
(PBS), pH 7.4, then embedded in paraffin or frozen in optimal cutting temperature compound (OCT, 
Tissue Tek) for sectioning. Immunohistochemistry was performed on 8 µm cryosections that were fixed in 
4% paraformaldehyde. The sections were stained for times ranging from 1 hr to overnight with the 
primary antibody that was diluted in blocking solution. H & E staining was carried out on paraffin 
sections of 5 µm thickness using the tissue stainer COT 20 (Medite). For BrdU labeling, 2-day lactating 
females were intraperitoneally injected with 100 µg BrdU (Sigma)/g body weight 2 hr prior to sacrifice.  
Paraffin sections of the mammary glands were incubated with a monoclonal antibody against BrdU and 
stained with a mouse ABC staining system (Santa Cruz). For the detection of cell apoptosis, paraffin 
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sections were TUNEL (terminal deoxynucleotidyl transferase mediated dUTP nick end labeling) -stained 
using the In Situ Cell Death Detection Kit, AP (Roche). 
 
Electron microscopy 
Pieces of mammary gland from 14-day lactating females were fixed in 3% paraformaldehyde, 0.5% 
glutaraldehyde in 10 mM PBS (pH 7.4) for 1 hr. The tissue was rinsed in PBS then post-fixed in 1% 
osmium tetroxide in PBS for 1 hr and dehydrated in an ascending series of ethanol solutions followed by 
15 min in acetone. Specimens were infiltrated with Epon:acetone (1:1) then Epon:acetone (2:1) for 1 hr 
each, followed by pure Epon for 4 hr. Polymerization was carried out at 60° C for 24-48 hr. Ultrathin 
sections were cut, mounted and contrasted with 6% uranyl acetate for 60 min, followed by lead acetate for 
2 min. Sections were viewed under a Leo 910 transmission electron microscope.    
 
Isolation and assays with primary mammary cells 
Primary mammary cells were prepared from control and β1 integin mutant females (Pullan, 1996a). The 
cultures consist of > 80% epithelial cells, as attested to by pan-keratin staining.  Freshly prepared cells 
were used to perform adhesion assays: 7 x 104 cells were plated in 96 well dishes pre-coated with poly-D-
Lysine (500 µg/ml, Sigma), collagen type I (50 µg/ml, Roche), fibronectin (25 µg/ml, Gibco), laminin (20 
µg/ml, Sigma) or gelatin (1 mg/ml, Sigma). After one hour, unattached cells were washed away and 
adhered cells were fixed, stained with crystal violet, solubilized in 1% SDS and the absorbance was read 
at 595 nm. 
In order to ablate β1 integrin and FAK in vitro, primary cultures were prepared from pregnant Itgβ1flox/flox 
and FAKflox/flox mice. In the FAKflox/flox mice, LoxP sites flank the exon that contains the ATP loop in the 
kinase domain and Cre-mediated excision results in a frame-shift that prevents FAK protein expression. 
Primary cells were infected in suspension with Adeno-Cre or Adeno-β−galactosidase virus for 45 
min(Watkin et al.,2002), before plating and culturing for another two days. More than 95% infection was 
verified by immunostaining with antibodies to Cre or β-galactosidase. zVAD was added for the final 24 hr 
to protect against possible cell death. 
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Transplantation of mammary epithelium into cleared fat pads of recipient mice  
Inguinal mammary glands of syngeneic 21-day-old females were cleared of mammary epithelium as 
described (Deome et al., 1959). Mammary glands from 3-day lactating control or β1 integrin mutant mice 
were dissected, chopped into pieces of approximately 1mm3 and transplanted into the cleared fat pads. Ten 
weeks after transplantation, recipient females were mated and at pregnancy-day 16, mice were sacrificed 
and mammary gland whole mounts were prepared. In this experiment, six mice were transplanted with 
tissue pieces from wild type and six with tissue pieces from β 1 integrin mutant mice. 
 
Lysate preparation, immunoprecipitation and western blot analysis. 
To prepare lysates from mammary glands, the frozen tissue was ground to a powder in liquid nitrogen and 
homogenized in lysis buffer containing 10 mM HEPES (pH 7.5), 100 mM KCl, 5% glycerol, 1% Triton-
X-100, 0.1% SDS, 10 mM EDTA, 1 mM DTT, 0.5 mM PMSF, 10 µg/ml Aprotinin, 10 µg/ml Leupeptin, 
1 mM Na3VO4, and 10 mM sodium molybdate. Cell lysates were prepared in NP40 lysate buffer (Lane et 
al., 2001). Cell lysates were subjected to SDS-PAGE, then transferred to PVDF membranes, which were 
blocked in 10% horse serum (GIBCO) or 5% nonfat milk for 1 hr and incubated overnight at 4°C with 
specific antibodies. Membranes were then incubated with the secondary antibody (Amersham) and signals 
were detected by enhanced chemiluminescence (ECL; Amersham) 
 
MDA-MB-231 cell culture, siRNA transfections and luciferase assays 
MDA-MB-231 cells were cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal 
calf serum (Gibco-BRL). For siRNA transfection, cells were seeded in 6-well plates and transfected 24 hrs 
later with siRNA duplexes (100 nM) using OligofectAMINE (Invitrogen), according to the manufacturer’s 
protocol. The 21-mer oligoribonucleotide pairs (Qiagen) were as follows: for integrin β1 (accession 
number NM-033669) nucleotide 167-189, for p21Cip1 (Accession number NM-000389) nucleotide 236-
254, for control LacZ (accession number NM55068) nucleotide 4277-4297 (obtained from D. Cappellen, 
FMI). Two days after siRNA transfection, cells were trypsinized, counted and plated either for 
immunohistochemistry on collagen I coated wells or for proliferation assays. Cells were stained with a P-
FAK specific antiserum 24 hr after plating; 48 hr after replating cell proliferation was measured. For 
transient transfections with plasmids, cells were plated at a density of 1 x 105 per well in 6-well dishes. 
One day later cells were transfected with a DN-FAK expression vector (FRNK, from Dr. Schlaepfer, 
Scripps, CA), a p21Cip1 reporter plasmid (WWP-Luc reporter plasmid from Dr. Vogelstein) and a Renilla 
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plasmid (Promega) using the Tranfection Reagent Effecten (Qiagen). Two days later, lysates were 
prepared and the luciferase assay was performed with Dual-Luciferase Reporter Assay Systerm (Promega), 
according to standard procedures. To control for transfection efficiency, Luciferase activity was 
normalized to the Renilla control.   
 
Flow cytometric analysis  
Cells were transfected with siRNA for LacZ, β1 integrin or p21Cip1 as described above. After 3 days cells 
were pulse-labeled with 10 µΜ BrdU for 1hr, then harvested and stained using the BrdU Flow Kit (BD 
pharmingen) according to the manufacturer's protocol.  BrdU-positive cells were detected using a 
fluorescein isothiocyanate-conjugated anti-BrdU antibody and DNA was stained with 7-amino-
actinomycin D. Cell cycle position of the BrdU-labeled cells was determined by two-color flow cytometric 
analysis. 
 
Extraction of RNA and RT-PCR analysis of p21Cip1
RNA was prepared by the Trizol method (GiBCO) and purified using the RNAeasy kit (Qiagen). Purified 
RNA was reverse transcribed and PCR amplified by standard procedures using the specific 
oligonucleotide primers for p21Cip1 (F: 5’- GGACCTGTC ACTGTCTTGTA- 3’; R: 5’- 
CTTCCTCTTGGAGAAGATCAG -3’) and actin (F:5’-CCTTCCTGGGCATGGAGTCCT-3’; R: 5’- 
GGAGCAATGATCTTGATCTT –3’). 
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